Illicit drug markets in Ireland. by Connolly, Johnny
Improving people’s health through research and information
drugnet 
Ireland
alcohol and drug research newsletter
Issue 52 
Winter 2014
 > Local residents’ views  
on illicit drug markets
 > Irish drug policy 
progress in 2013
 > Urban and rural youth  
in treatment 
 > Suicide study
 > Rehabilitation pilot 
evaluation
 > Quality training  
for services
 > Voluntary services 
publish annual reports 
for 2013
 > New tool to assess  
policy coherence
To have Drugnet Ireland  
delivered to your desktop,  
sign up on the NDC website
www.drugsandalcohol.ie
Drug and alcohol 
evidence reviews 
published
Illicit drug markets in Ireland
The first national study on 
illicit drug markets in Ireland, 
conducted by the Health Research 
Board, was recently published by 
the National Advisory Committee 
on Drugs and Alcohol (NACDA).1 
The study provides in-depth 
research and analysis on the 
various factors that influence 
the development of local drugs 
markets; the nature, structure and 
organisation of the Irish drugs 
market; the impact of drug-
dealing on local communities; 
and an evaluation of current 
interventions in response to illicit 
drug dealing. This article provides 
a summary of the key findings of 
the study.
This exploratory study was 
conducted over a 36-month 
period (from 2008 to 2010) and 
included a cross-section of four 
local drug markets: two urban, 
one suburban and one rural drug 
market (anonymised as A–D). 
The study adopted a mixed 
methodological or triangulation 
approach to the investigation. This 
included the following: 
 ■ face-to-face in-depth interviews with both former and active drug users and street sellers 
and with individuals serving prison sentences of more than seven years for drugs supply;
 ■ 24 interviews with experienced members of dedicated garda drug units in the four study 
sites and with senior members of the Garda National Drugs Unit;
 ■ Interviews with drug treatment workers, public health specialists and a family  
support group;
 ■ a street survey of 816 local residents and business people (approximately 200 respondents 
in each location);
 ■ analysis of 1,200 drug offences and seizures on the Garda PULSE IT system throughout the 
four study sites and nationwide seizures made by Customs Drug Law Enforcement (CDLE) 
from 18 stations; and
 ■ analysis of cocaine and heroin purities and adulterants in all study sites by the Forensic 
Science Laboratory. 
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Evolution and organisation of illicit drug markets 
When asked what they thought were the main reasons 
for local drug use, most survey respondents highlighted 
social issues, with drug use seen as a symptom of deeper 
underlying factors. These included the absence of facilities 
for young people, high unemployment, boredom, poor 
parental supervision and drug availability. A number of 
explanations were also advanced during interviews as to how 
illegal drugs entered the areas. Factors mentioned included 
the relocation of people from deprived urban centres to 
suburban and rural areas, the influence of prison where 
people had developed addictions and/or met people who 
would subsequently introduce them to drug-dealing, and the 
arrival in an area of people, both national and non-national, 
with heroin habits. 
Despite popular portrayals of illicit drug markets as 
hierarchical entities controlled by organised crime groups, 
recent international research has emphasised a more 
complex, decentralised and fluid phenomenon involving 
numerous participants, most of them strangers to each 
other.2 The findings of this research correspond with this 
more nuanced perspective. There were a number of key 
differences in how drug markets were organised across 
the four sites surveyed, from more loosely structured to 
more co-ordinated arrangements. Site D, for example, was 
highly structured in terms of distributing heroin, cocaine 
and cannabis, with several high-level suppliers involved in 
drug importation and distribution over this very wide area. 
The middle market in this location was reportedly heavily 
populated with individuals and groups or ‘gangs’ supplying 
kilograms or more. Although crack cocaine had originated 
with West Africans in site D, it now involved more Irish 
sellers. In site C, the distribution of drugs such as cannabis 
and cocaine was concentrated among a small number of 
established families. Heroin distributors were described 
as non-local, both Irish and non-Irish, who had arrived in 
the area with an addiction. The heroin market was also 
described as less structured and easier to penetrate from a 
law-enforcement perspective. In site B, the heroin supply 
was regarded as having originated within specific families 
but more recently it involved a looser network of individuals. 
Heroin was not imported directly but sourced from the 
major cities of Dublin and Limerick. Cocaine distribution 
in site B was more structured and lucrative and dominated 
by a particular group of individuals who used legitimate 
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Illicit drug markets (continued)
businesses as a means of transporting drugs throughout the 
region. Across all sites, it was found that a large number 
of individuals performed roles on behalf of higher-level 
suppliers. Another common factor we found across all sites 
was that higher-level suppliers usually avoided any contact 
with drugs once they had been imported.
In site A, a large number of individuals performed roles on 
behalf of higher-level suppliers, including diluting or preparing 
drugs. Those involved in the storage and transport of drugs 
were generally relatively minor participants, either earning 
drugs for their own use or trying to pay off a drug debt. The 
involvement of young people in the drugs trade was also a 
factor. In site A, young people played a substantial role in 
drug distribution at street level. Storing or running drugs was 
a financially lucrative option for teenagers. Over a six-month 
period, PULSE data revealed that one-fifth of suspected 
supply offenders were aged 18 or younger. (PULSE [Police 
Using Leading Systems Effectively] is the computer system 
that the Gardaí use in their work.) Not all these runners used 
drugs themselves and some were doing it as a way of earning 
money. The profile of runners was different in site B. They 
were often older heroin addicts running drugs in return for a 
personal supply. Non-drug-using young people (aged under 
18) were not reported as playing a significant role in drug 
distribution. Similarly, in site C, although runners did exist, 
there was little evidence to suggest the involvement of very 
young people (aged 16 and under). It was reported that this 
would not have been tolerated by local residents. By contrast, 
in site D, young people were reported to be heavily involved 
in running drugs. 
The main drug sold across all four sites surveyed was 
cannabis. Heroin, crack cocaine and prescription drugs 
could be purchased at different levels in all areas. All the 
main drugs were available in all four study locations, 
although heroin was a relatively recent phenomenon in site 
C. The research indicated that some dealers sold multiple 
substances. PULSE data also suggested a degree of overlap 
between drug types, with multiple substances often being 
seized from the same individual in supply type offences. 
However, there were also many sellers who concentrated on 
only one substance, such as cannabis.
Where drugs are sold was shown to vary across sites – not 
all drugs were sold on the open market. No drugs were 
reported to be sold openly in sites B and C, yet sites A and 
D had several highly visible open street-level markets, often 
located in the midst of legitimate commercial businesses. In 
site A, dealers took turns to sell drugs to buyers who came 
from outside the area. Across all sites, it was reported that 
closed markets were to be found in pubs and flat complexes. 
There were thriving open markets for crack cocaine in 
sites A and D, while site B, which was a rural town, had an 
emerging crack problem. Drug sellers in all sites reported the 
increased use of mobile phones to assist in the carrying-out 
of drug transactions. 
Impact of illicit drug markets 
When asked if they avoided areas in their neighbourhood 
(and why), many respondents noted that this was mainly 
because of people hanging around in groups taking drugs. 
This figure varied across the sites, however – from almost 
three-quarters of respondents in site A to under half of 
respondents in site D (40%). Most respondents considered 
illegal drugs to be a big problem in their area (ranging from 
67% of respondents in site C to 90% in site A). However, 
we found that residents’ direct exposure to drug problems, 
whether through witnessing drug-using behaviour or seeing 
discarded syringes in their neighbourhoods, varied. 
All four sites reported an increase in violence associated with 
the drug trade – violence that was increasingly visible in public 
in the form of fights or damage to property. Violence in all 
four markets was largely related to unpaid debts, although 
territorial disputes did occasionally emerge in less ordered 
drug markets. Drug debts were acquired through people 
consuming their own supply or as a result of Garda seizures. 
Where gardaí seized drugs, debts remained outstanding and 
still had to be paid. This may be described as an unintended 
or adverse consequence of drug law enforcement, whereby 
effective supply reduction activities can indirectly contribute 
to greater levels of drug-related violence. In site A, drugs were 
provided on credit at all levels of distribution and most of the 
violence related to money owed. 
Drug market disputes over debt or territory could also ‘spill 
over’ into public displays of violence, or innocent third 
parties could become embroiled in such conflicts. In site 
A, in a busy open street market for crack cocaine, dealers 
took turns in selling to new buyers. If one dealer began to 
dominate, however, this could contribute to conflict, which 
could lead to public fights. However, not all drug markets 
studied here can be described as equally violent. In site C, 
where the drug market was described as competitive but 
relatively ordered, with everyone ‘knowing their place’, 
violence was almost always related to drug debts.
Our research found that one of the major consequences 
of drug-related violence and intimidation is that it can 
act as a major disincentive to residents or local business 
people taking action and/or engaging with state agencies 
in responding to such problems. Explaining their refusal to 
report local drug-related problems, the majority of residents 
in all locations stated their fear of reprisal from those involved 
in the drug trade. 
It must also be acknowledged that drug markets can have 
an ambiguous relationship with their ‘host’ communities: 
although there may be opposition to them – particularly 
in terms of the stigma they can bring to the local area – 
they can also provide a source of cheap goods in deprived 
communities. Residents in all four study sites reported being 
offered stolen goods by people they suspected of being 
drug users. Interviews with drug users and sellers revealed 
that stolen property was an important currency in everyday 
drug transactions, so there was clearly a local market for 
Dr Johnny Connolly, 
HRB, lead author of 
Illicit drug markets  
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the proceeds of drug-related crime. Stolen goods, such as 
jewellery, mobile phones, satellite navigation devices and 
computer games were regularly exchanged for drugs. Stolen 
goods were either retained by the dealer for their personal 
use or they were sold in the local community.
Law enforcement responses
With regards to drug seizures, the air mail unit (Dublin), the 
Athlone mail centre and Dublin airport passenger terminal 
accounted for most of the seizures made by Customs Drug 
Law Enforcement (CDLE) during the research period. The 
drugs seized were generally en route from source/transit 
locations such as Amsterdam, South Africa or South America. 
Mail stations such as Portlaoise reported a high rate of low-
volume seizures of substances such as cannabis, and licit but 
prescribed medication such as benzodiazepines.
Of the 1,378 CDLE seizures of illegal or controlled drugs 
between January and June 2009, 90% were of cannabis herb 
or resin. The vast majority (90%) of these seizures weighed 
less than 28g and were most likely for personal use. CDLE 
made 52 seizures of illegal substances that weighed 1kg 
or more (4% of total seizures). Cocaine and cannabis herb 
accounted for 89% of these seizures. It is not possible to 
determine accurately the proportion of these drugs that were 
destined for the Irish market or whether these seizures had 
any significant impact on drug availability in Ireland.
Garda Síochána drug unit strategy focused on middle-market 
suppliers, primarily using intelligence from informants. Such 
intelligence was acquired through developing relationships 
with offenders working in the lower levels of distribution. 
It was shown across all four sites that supply offences 
accounted for between 17% and 33% of all drug offences, 
and that the largest proportions of supply offences were in 
sites A and D. On the one hand, this reflects the intelligence-
led and focused nature of activity by individual Garda drug 
units. On the other, it reflects the greater availability of drugs 
in these areas. While some drug sellers acknowledged the 
importance of being wary of Garda activity, our research 
showed no evidence that drug availability was affected for 
any significant period because of successful law enforcement. 
In all four sites, most prosecutions were for simple possession 
of cannabis: most of these related to stop and search activity 
by Garda members and the amounts seized were valued at 
between €10 and €20. Local tolerance of cannabis use was 
highlighted by Garda members and by treatment workers in 
a number of sites.
Assessing impact of drug-related  
law enforcement
Drug availability
The report highlights the challenges that arise in any attempt 
to assess the effectiveness of responses to illicit drug markets. 
Such problems are related to the obvious difficulties in trying 
to account for largely hidden activities, but they are due 
also to the limitations of criminal justice data. Moreover, 
the absence of reliable evidence of a straightforward 
link between supply-reduction initiatives and sustained 
reductions in drug availability has been highlighted in the 
international literature.2 The public demand for illegal drugs 
and the profits which can be earned from drug-dealing 
ensure that Irish drug markets, like those elsewhere, remain 
resilient and adaptable to law-enforcement interventions. 
For instance, a convicted drug courier claimed that he had 
smuggled cannabis across Europe into Ireland for many 
years without detection. For this individual, the transporting 
of drugs was a lucrative business and one in which he 
participated for monetary gain. Also, a number of imprisoned 
non-national female drug couriers interviewed for the 
study, who had been apprehended in airport passenger 
terminals, generally reported being in desperate financial 
circumstances, and had agreed to courier kilograms of illegal 
drugs, sometimes for as little as €500. The incarceration 
of such individuals, while it removes some drugs from 
circulation, is unlikely to have any real impact on those 
individuals higher up the supply chain, and thus its effect on 
drug availability will be limited in the longer term. 
Market disruption
In sites A and D, despite several targeted operations, gardaí 
acknowledged that they were unable to disrupt market 
activity for any length of time, nor had they been able to 
displace activity to another location. The limitations of such 
Garda crackdowns in busy hotspots were also highlighted 
by local drug sellers, who would disperse quickly when 
gardaí approached and resume when they left the area. 
Drug sellers adapted to drug law enforcement by managing 
risk exposure. For instance, many interviewees did not keep 
drugs on their person: they would divide up consignments 
and leave them at different locations, for buyers to collect. 
Higher-level sellers often used others to transport drugs for 
them. Drug sellers also reported using people as decoys, 
where they would give them a small amount of drugs and 
then inform the gardaí so as to distract the latter from a 
larger drug-deal happening simultaneously elsewhere.
Engaging and reassuring communities
Another way of determining the impact of law-enforcement 
approaches is whether they reassure the public. Residents’ 
perceptions of Garda anti-drug activity were investigated 
in the street survey. In site A, only one-third of survey 
respondents believed the gardaí to be effective or 
very effective in dealing with crime. In sites B and C, 
approximately half of respondents believed gardaí to be 
effective or very effective in dealing with crime in their area. 
In site B, more than half of them knew a Garda by name, 
while in site C more than a third knew a Garda member 
by name. In site D, just under half of respondents believed 
gardaí to be effective or very effective in dealing with crime, 
while 36% of residents said they were not very effective. Just 
one quarter of respondents knew a Garda member by name 
and/or had spoken to a Garda about the area. These findings 
suggest that there may be a link between perceptions of 
Garda effectiveness and familiarity with Garda members 
working in the community; they support the findings of 
other research which suggest that police visibility can 
increase residents’ confidence in the ability of the authorities 
to address public nuisance.
Illicit drug markets (continued)
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Partnership responses 
Evidence is growing, both internationally and in Ireland, that 
partnership approaches involving drug law enforcement, 
local communities and other stakeholders offer the most 
sustainable method of responding to many drug problems, 
including illicit drug markets.3 Drug unit members’ contact 
with treatment providers varied across sites. In three sites (A, 
B and C), Garda members had little contact with local drug-
treatment agencies and factors such as confidentiality issues 
were cited as possibly preventing closer links. However, 
in site C, it was felt that better working relationships with 
social welfare services and housing authorities could produce 
beneficial outputs for all agencies involved. There was also 
doubt expressed about the suitability or effectiveness of 
Garda members taking a bigger role in diverting offenders  
to treatment. 
In site D, inter-agency partnership was developing and 
proving beneficial. The relationship with local municipal 
housing authorities was described as positive, and local 
housing authorities assisted efficiently in the eviction of drug-
dealers. Recent improvements in relationships with drug-
treatment services had also produced positive results such as 
the identification of persistent drug sellers stationed outside 
drug-treatment clinics. However, gardaí had no official 
relationships or structures to help guide problematic users 
and sellers to treatment.
Research implications
The study raises a number of general implications for future 
responses to illicit drug markets. First, the complete removal 
of illicit drug markets through drug law enforcement is not 
an achievable goal in the foreseeable future. The aim must 
be to consider how future drug law enforcement might 
evolve to address the complexities and particular harms 
associated with Irish drug markets. It is suggested that such 
an approach does not necessarily require a change in the 
legal control framework but rather a more pragmatic use and 
co-ordination of existing resources and the targeting of those 
resources at the most harmful aspects of drug markets. 
Second, not all drug markets are equally harmful. For 
example, some are more violent than others and open 
markets cause more disruption to communities than closed 
ones. Third, law-enforcement interventions that focus on the 
particular harms associated with a specific market have the 
potential to have an impact on those harms and they may 
also lead to a more effective and economically viable use of 
public resources. 
Finally, approaches that seek to divert problematic drug 
users into treatment and that prioritise local community 
perspectives, and those that occur in collaboration with 
other relevant agencies, are more likely to be sustainable 
over time and to win public support. 
The study concludes with a discussion about how to address 
four key challenges which, it is suggested, need to be 
overcome if such an approach is to be successful: 
 ■ how to deliver change through inclusive community-
based, inter-agency partnerships, 
 ■ how to engage with communities in light of the 
widespread localised fears that drug markets and those 
involved in them can create,
 ■ how to prioritise harms and use resources to their 
maximum effect, and
 ■ how to profile drug markets and monitor responses  
to them.
(Johnny Connolly)
1. Connolly J and Donovan A (2014) Illicit drug markets 
in Ireland. National Advisory Committee on Drugs and 
Alcohol and Health Research Board. Dublin: Government 
Publications http://www.drugsandalcohol.ie/22837/
2. Babor T et al (2010) Drug policy and the public good. Oxford: 
Oxford University Press
3. Connolly J (2006) Responding to open drug scenes, drug-
related crime and public nuisance – towards a partnership 
approach. Strasbourg: Council of Europe Pompidou Group; 
Jacobs K et al. (2007) Making sense of partnerships: a study of 
police and housing department collaborations for tackling drug 
and related problems on public housing estates. Project Report. 
Tasmania: National Drug Law Enforcement Research Fund 
4. May T and Hough M (2004) Drug markets and distribution 
systems Addiction Research & Theory 12(6): 549–63.
Illicit drug markets (continued)
Conceptualising drug markets
The illicit drug market can be understood as loosely 
incorporating three inter-related levels or dimensions. 
First, the global or ‘international market’ incorporates 
drug production and international trafficking; second, 
the ‘middle market’ involves the importation and 
wholesale distribution of drugs at a national level with 
research seeking to describe how drugs are moved from 
importation to street level and by whom; and third, the 
‘local market’ involves distribution at a retail level. 
May and Hough4 provide a classification of retail markets 
distinguishing between open markets, semi-open markets 
such as pubs and clubs, closed markets and crack or 
dealing houses. Some of their main features are described 
as follows:
 ■ Open Markets – open to any buyer with no 
requirement for prior introduction to the seller and 
few barriers to access.
 ■ Semi-open markets – pub and club-based markets, 
mostly for ecstasy and other drugs used by clubbers. 
Sellers will generally do business in the absence of any 
prior introduction, ‘provided the buyer looks the part’. 
 ■ Closed markets – sellers and buyers must know and 
trust each other, or be introduced by a mutual third 
party.
 ■ Crack/Dealing House Markets – Have evolved since 
early 1990s in UK. ‘Crack houses’ sell a wide range 
of illicit drugs and so are more accurately referred 
to as ‘dealing house markets’. Can be in residential, 
uninhabited or semi-derelict properties and often for 
a short period until enforcement closes them down. 
Can attract large numbers of buyers, often calling at 
day and night and are often associated with anti-social 
behaviour in the building or in the surrounding area. 
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Local residents’ views on illicit  
drug markets 
As part of the illicit drug markets study described in the 
previous article, a street survey of approximately 800 local 
residents and business people was carried out to gather 
information about the local community in relation to illicit 
drug use. The survey incorporated almost 60 questions 
related to local drug markets. Below we look at just three of 
the key responses – reasons for drug use, future responses 
needed and fear of drug dealers.
Perceived reasons for drug use
Residents were surveyed on the perceived reasons for drug 
use in the area. Of those who responded to the question, 
one quarter highlighted issues impacting on young people: 
unemployment, boredom, the absence of facilities and poor 
parenting. Seventeen per cent highlighted the availability 
of drugs.
Table 1: Perceived reasons for drug use (n=494)
n %*
High unemployment 117 23.6
Boredom 110 22.2
No facilities for young people 99 20
Poor parental supervision 96 19.4
Availability of drugs 86 17.4
Poor education 55 11.1
Poverty 43 8.7
It’s just the way society is 41 8.2
Other 34 6.8
*Percentages exceed 100% as multiple answers permitted; 
‘don’t knows’ excluded. 
Future responses needed
With regards to the measures needed to reduce drugs and 
crime, almost 50% highlighted the need for improved 
amenities for young people along with education and 
awareness programmes targeted at young people. However, 
a clear majority across all four study locations called for 
an increase in the number of gardaí visible on the streets, 
patrolling. Despite other findings of the study to the effect 
that the gardaí could only have limited sustained impact 
on local drug markets, clearly the importance of a police 
presence is regarded as crucial. On the one hand this reflects 
the reassurance that a police presence can bring to local 
residents; on the other hand it reflects the idea that such a 
continuous presence can help ensure open drug markets 
do not become entrenched in an area. Police patrolling can 
ensure that drug markets are continuously disrupted.
Table 2: Measures needed to reduce drugs and crime, site A 
(n=560) 
n %*
More gardaí on the streets/
patrolling
276 49.2
Improved amenities for  
young people
167 29.8
Education and awareness 
programmes targeting  
young people
102 18.2
Other 76 13.5
Harsher sentencing for dealers 74 13.2
More drug-treatment facilities 37 6.6
Regeneration of housing estates  
and flat complexes
37 6.6
Increase in family support services 19 3.3
Increased social services in the area 12 2.1
*Percentages exceed 100% as multiple answers permitted; 
‘don’t knows’ excluded. 
Fear of drug dealers
The need for a local police presence is also highlighted in 
Table 3 below. The research found that one of the major 
consequences of drug-related violence and intimidation is 
that it can act as a major disincentive to taking action and/
or engaging with state agencies in responding to such 
problems. When asked whether they would report drug-
related information to the gardaí and, if not, why not, 
most respondents (41.4%) highlighted their fear of reprisal 
from those involved in the drug trade. In National Crime 
Victimisation Surveys, such as those conducted by the 
Central Statistics Office, fear of reprisal is never reported as 
a significant reason for people not reporting crimes to the 
Garda Síochána.1 Twenty-three per cent believed that the 
gardaí would not act or stated that they did not wish to 
involve gardaí; a further 23%responded that it was not their 
business; and almost 10% stated that they did not want to 
be seen as a ‘grass’, or informer.
Table 3: Reasons for reluctance to report drug-related 
information to gardaí (n=251)
Reason n %*
Fear of reprisal 104 41.4
Not my business 59 23.5
Gardaí would not act 33 13.1
Don’t want to be a grass 25 9.9
Would not wish to involve gardaí 25 9.9
Social reasons 22 8.7
Other 13 5.1
*Percentages exceed 100% as multiple answers permitted 
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The fear and intimidation that can be generated locally as a 
consequence of illicit drug dealing reveal the insidious and 
disproportionate impact that crime can have on specific 
locations where drug markets develop. It also represents a 
significant policy obstacle in terms of obtaining community 
consent or participation in community-based and partnership 
responses to crime. A number of interview respondents 
commented on this very real issue. The following imprisoned 
drug dealer felt that, although violence has always been 
associated with the illicit trade in drugs, the debt-related 
intimidation of family members of those who owed money 
to drug-dealers was relatively recent.
Violence, it was, it was always in it. It was part and parcel 
of like you get stigmatised, you know, drugs – with drugs 
comes violence and it is true. With drugs comes violence but 
I was never violent. I was always sympathetic to those who 
went off them, always. I would never go around as they do 
now fucking like tapping on doors, looking for the aul’ fella, 
looking for the fathers or mothers to pay but I was never 
like that. I would write it off – more times out of 10 like 
if I got out of pocket from doing it, but I would never use 
violence. 
Prison Interview
(Johny Connolly)
1. Central Statistics Office (2009) Quarterly National Household 
Survey: Unemployment. Available at: www.cso.ie See also 
Connolly J (2003) Drugs, crime and community in Dublin: 
monitoring quality of life in the north inner city. Dublin: North 
Inner City Drugs Task Force
Local residents’ views (continued)
Ireland’s drug policy – progress in 2013
Since 2001 Irish governments have endorsed the national 
drugs strategy (there have been two) as Ireland’s national 
drug policy. Each year the Department of Health publishes 
a progress report on implementing the actions contained in 
the strategy. 
In recent years Ireland’s newly-elected coalition governments 
have also published a ‘programme for government’, 
outlining the government’s priorities and objectives across all 
policy domains. In the current programme for government, 
national policy on illicit drugs, alcohol and tobacco is 
discussed in the chapter entitled ‘Fairness’, along with 
government policies on health, education, criminal justice 
and a range of other social issues. Each year the government 
publishes a report on progress in implementing this 
programme for government.
Some of the highlights, as reported in the 2013 progress 
reports on the implementation of the programme for 
government and the national drugs strategy, are  
listed below.1 
Following the government’s self-report, an assessment 
by a civil society organisation (CSO) of the government’s 
performance in relation to alcohol and drug policy in 2013 
is outlined.2 Focusing on areas where there has been little 
progress, this assessment is notably more critical. However, it 
also suggests how progress in developing and implementing 
policy could be made. The implications of the difference 
of perspective between government and non-government 
sources are considered in a separate article – ‘Who should 
decide national drug policy?’
Tobacco-free Ireland
As part of Healthy Ireland, a new government framework for 
action to improve the health and wellbeing of Irish people, 
Tobacco Free Ireland was published – a strategy for making 
Ireland tobacco free by 2025.
National substance misuse strategy
The government approved a package of measures to deal 
with alcohol misuse, to be incorporated in a Public Health 
(Alcohol) Bill. It will cover minimum unit pricing, regulation 
of marketing and advertising, structural separation of alcohol 
from other products in mixed trading outlets, enforcement 
powers to be given to Environmental Health Officers, 
and health labelling to include warnings and advice. The 
regulation of sports sponsorship was given back to a working 
group for further examination.
Supply reduction
Drug seizures for the first three quarters of 2013 were 
estimated to have a provisional value of €67 million and An 
Garda Síochána’s Operation Nitrogen continued to be very 
successful in identifying and dismantling cannabis cultivation 
sites across the country. Revenue drug-smuggling detection 
seized €20.8 million in drugs and €20.7 million in illegal 
tobacco and cigarettes. The Criminal Assets Bureau returned 
approximately €6 million to the Exchequer in 2013, the 
majority of which resulted from drug trafficking but also 
some from tobacco smuggling.
Drug-related policing
The Department of Health progress report for 2013 records 
that (1) guidelines for the operation of local policing fora 
(LPF) in LDTF areas and other areas experiencing serious 
and concentrated drug misuse problems were circulated to 
the relevant bodies for implementation; (2) a drug-related 
intimidation programme was established jointly by An 
Garda Síochána, the Family Support Network and the HSE’s 
Social Inclusion Unit to respond to the needs of drug users 
and their families and friends who may be experiencing 
intimidation to pay drug debts; and (3) a framework was 
developed to support the nomination of an Inspector 
in every Garda division to target adults involved in the 
drugs trade who use children to engage in illegal activities 
associated with the drugs trade.
Drugs in prisons
A full range of security initiatives continued to be 
implemented to eliminate the supply of drugs into prisons, 
and drug-free units continued to be rolled out in all closed 
prisons. These units accommodate and cater for the needs 
of both drug-free prisoners and those prisoners stable on 
methadone. There were 522 places filled in drug-free units 
operating across nine closed prisons, with 35 places due to 
become operational shortly in Portlaoise Prison.
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Prevention
The HSE established a National Hidden Harm Project 
Management Group to ingrain awareness of hidden harm 
into the overarching substance misuse and childcare policy 
frameworks, in order to bridge the gulf between the two 
systems and ultimately to improve outcomes for children. 
A key performance indicator (KPI) in the national drugs 
strategy, to reduce early-school leaving from 11.5% in 2007 
to 10% by 2012, had been exceeded: the figure for 2012 
was 9.7%, below the EU average of 12.8%.
Drug treatment and rehabilitation services
In 2013, €91.5 million (not including funding of community 
and voluntary and prison-based services) was allocated for 
the HSE’s Addiction Services. Over 12,500 people received 
drug treatment for all types of drug use, including over 
9,600 people in opioid substitution treatment. At the end of 
2013 almost 100% of people over the age of 18 could access 
treatment within one month of assessment, and almost 
100% of children could access treatment within one week of 
assessment. 
The HSE’s National Addiction Training Programme (NATP) 
provided an introduction to dual diagnosis (DD) as an 
awareness-raising exercise. Following an initial presentation 
to staff of addiction and allied health and social care services 
in Bridge House in Cherry Orchard Hospital, conferences 
were held for wider audiences. 
The HSE National Hepatitis C Strategy Implementation 
Committee was established and set up three sub-groups to 
progress the recommendations in the hepatitis C strategy 
– Treatment; Surveillance and Screening; and Education, 
Prevention and Communication.
A National Rehabilitation Framework to improve the quality 
and quantity of interagency referrals between drugs services 
was implemented on a phased basis at ten pilot sites across 
the country. A process evaluation was completed during 
2013, and an implementation plan for national rollout of the 
framework is being developed in 2014.
Drug-specific Community Employment (CE) 
schemes
With a budget of almost €15 million in 2013, drug-specific 
CE schemes facilitated stabilisation and recovery from 
problem drug use by providing individual care plans and 
tailored supports for clients. At the end of 2013 there 
were 790 participants on drug-specific CE schemes and 
161 support workers. The proportion progressing onto 
employment or further education/training as at December 
2013 was 28.3%.
The view from civil society
In February 2014 the Children’s Rights Alliance (CRA) issued 
its annual report card evaluating the government’s progress 
during 2013 in meeting its commitments to children, as set 
out in the Programme for Government.2 Alcohol, illicit drug 
and tobacco policies are assessed in Chapter 3, ‘Right to 
Health’; five pages are devoted to reviewing the evidence 
and discussing the policy options. 
CRA concludes that progress in 2013 was ‘very slow’: 
apart from the Tobacco Free Ireland Report published in 
October 2013, the promised national addiction strategy 
had not been published, there was no government policy 
on tackling alcohol misuse, and no government decision 
on recommendations of the steering group on the alcohol 
section of the national substance misuse strategy. The 
government is given a ‘D+’ grade for its alcohol and drug 
policies, a slight improvement on 2013 (‘D-’), reflecting the 
‘initial steps taken towards creating a Tobacco Free Ireland 
and some positive movement in relation to alcohol’. But 
concrete actions are called for.
(Brigid Pike)
1.  Department of Health (2014) National Drugs Strategy 
2009–2016: progress report to end 2013. Dublin: Department 
of Health http://www.drugsandalcohol.ie/21621/ and 
Government for National Recovery (2014) Programme for 
Government: annual report 2014 http://www.taoiseach.
gov.ie/eng/Work_Of_The_Department/Programme_
for_Government/Programme_for_Government_Annual_
Report_20141.pdf 
2. Children’s Rights Alliance (2014) Report card 2014: is 
government keeping its promises to children? Dublin: Children’s 
Rights Alliance. The Children’s Rights Alliance is a coalition of 
over 100 civil society organisations, including the Ana Liffey 
Drug Project, which works to secure the rights of children 
in Ireland, by campaigning for the full implementation of 
the UN Convention on the Rights of the Child. It aims to 
improve the lives of all children under 18 years, through 
securing the necessary changes in Ireland’s laws, policies and 
services. http://www.childrensrights.ie/ 
Who should decide national drug policy?
The previous article ‘Ireland’s drug policy – progress in 2013’ 
pointed to a difference of perspective between government 
and non-government sources in how progress was assessed. 
This contrast highlights the issue, who should be responsible 
and accountable for drug policy? How might different, even 
conflicting, views and approaches be reconciled or a balance 
struck? These types of question are the theme of a recent 
special edition of the International Journal of Drug Policy – 
‘Towards good governance in drug policy’.1 
Understanding governance
The editors of the special edition note a consensus in the 
burgeoning literature on the importance of governance: 
given the increasing complexity of societies, intensifying 
globalisation and accelerating technological change, new 
processes of governing drug policy are essential. Drawing 
on a range of authors, the editors characterise governance 
as follows: the interest in governance comes from a desire to 
understand how societies or organisations ‘steer’ themselves, 
are ‘directed, controlled and held to account’; governance 
encompasses a complex mesh of interacting events and 
actors, ‘multiple agencies and sites, with action on many 
levels, from global to local’; and the way to approach the 
Ireland’s drug policy 2013 (continued)
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study of governance is to look at the structures, processes 
and mechanisms through which policy is ‘informed, made, 
implemented and assessed’. 
The editors acknowledge the work of three policy research 
groups in the study of governance in illicit drugs policy – 
the Australian-based Drug Policy Modelling Program; the 
UK Drug Policy Commission, which wound up in 2012, 
after five years; and ALICE RAP (Addictions and Lifestyles 
in Contemporary Europe – Reframing Addictions Project) 
funded by the European Commission’s 7th Framework 
Programme. Many of the authors of the empirical  
accounts and critical analyses (15 in total) included in  
the special edition are or have been associated with one  
of these entities.2 
Reflecting on the assembled articles, the editors observe that 
the policy decision process in relation to illicit drugs needs to 
be ‘flexible’, adapting to different substances and contexts, 
and ‘appropriate’ to different local and national needs and 
cultures. Although transparency is a desirable feature of 
any policy process, the editors note how some of the most 
effective (i.e. realistic, cooperative and science-based) drug 
policy has emerged behind closed doors, away from the 
media and the general public. They conclude:
But decisions taken by experts and insiders are not what 
representative democracy is supposed to be about. The 
challenge for proponents of good governance is to show 
how to marry the goals of transparency and democratic 
accountability with respect for logic and evidence. 
What constitutes ‘good governance’?
One of the editors of the special edition is also co-author 
of an article that identifies the key requirements for good 
governance: goals; leadership and coordination; use of 
evidence; feedback and learning; stakeholder engagement; 
accountability; and a ‘safe space in which debate can take 
place’.3 However, the editors point out that many of the case 
studies problematise this ideal: government agendas, public 
concerns and expert opinion are often at odds, and including 
all relevant stakeholders in the policy process and seeking to 
incorporate all their views may well result in ‘a compromise 
(mish-mash or fudge) of contradictory and opposing views 
with no settled resolution’. Lancaster and Ritter conclude 
that effective collaboration might be possible through 
building shared values and interests and developing mutual 
trust through greater use of mechanisms such as committees 
and networks.4 
What counts as ‘evidence’?
Not an easy question to answer. Monaghan highlights 
the need for a clear definition of what counts as evidence, 
including specific criteria for inclusion/exclusion, and 
determining how to accommodate competing expert, 
ideological and political perspectives on what constitutes 
evidence.5 Using a social constructionist approach, Lancaster 
questions whether researchers can ever really be apolitical 
and independent producers of ‘policy-relevant knowledge’. 
She suggests they answer questions posed by wider society 
and the resulting evidence is inevitably enmeshed in a 
particular policy context.6 
Who are the ‘stakeholders’?
The stakeholders are those who have an impact on policy, 
or are impacted on by policy. They include a wide range of 
different groups and actors. Stakeholders may come from 
various disciplines such as science, medicine or journalism, 
from different sectors such as public or private sector or 
civil society, and will reflect a wide variety of ideologies, 
values and belief systems. Two separate case studies, about 
the introduction of drug consumption rooms in Denmark, 
and the provision of opioid substitution treatment England, 
demonstrate how the outcome of a policy process reflects, 
and is to some extent determined by, who has participated 
or been excluded from participation, and also by the relative 
power of different groups and individuals.7 
(Brigid Pike)
1.  MacGregor S, Singleton N and Trautmann F (2014, 
September) Towards good governance in drug policy: 
Evidence, stakeholders and politics. Editorial. International 
Journal of Drug Policy (25/5): 931–934.
2.  For more information on these three entities, visit https://
dpmp.unsw.edu.au/ ; http://www.ukdpc.org.uk/ ; http://
www.alicerap.eu/ 
3.  Singleton N and Rubin J (2014) What is good governance in 
the context of drug policy? International Journal of Drug Policy 
(25/5): 935–941.
4.  Lancaster K and Ritter A (2014) Making change happen: 
a case study of the successful establishment of a peer-
administered naloxone program in one Australian 
jurisdiction. International Journal of Drug Policy  
(25/5):985–991.
5.  Monaghan M (2014) Drug policy governance in the UK: 
lessons from changes to and debates concerning the 
classification of cannabis under the 1971 Misuse of Drugs 
Act. International Journal of Drug Policy (25/5):1025–1030.
6.  Lancaster K (2014) Social construction and the evidence-
based drug policy endeavour. International Journal of Drug 
Policy (25/5): 948–951.
7.  Houborg E and Frank VA (2014) Drug consumption rooms 
and the role of politics and governance in policy processes. 
International Journal of Drug Policy (25/5): 972–977; Duke K 
and Thom B (2014) The role of evidence and the expert in 
contemporary processes of governance: the case of opioid 
substitution treatment policy in England. International Journal 
of Drug Policy (25/5):964–971.
Who should decide drug policy? (continued)
10
drugnet 
Ireland
Towards UNGASS 2016
Since Issue 48, Drugnet Ireland has carried ‘Towards UNGASS 
2016’ as a regular column. It reports briefly on policy 
initiatives, research and debates launched by UN member 
states and civil society organisations in the lead-up to the UN 
General Assembly Special Session (UNGASS) on the world drug 
problem, due to be held in 2016 (A/RES/67/193).
Released in July 2014, From drug war to culture war: Russia’s 
growing role in the global drug debate is the fifth policy brief 
published by the Global Drug Policy Observatory (GDPO) 
based in Swansea University. Prepared by Alexander Marshall, 
the policy brief outlines how, in the last decade, Russia’s 
drug policy has shifted from a ‘health and psychiatric-
dominated discourse’ towards a ‘securitisation model’ 
and a ‘conservative cultural discourse’. Marshall describes 
how Russia has used this general drug war discourse to 
increase its levers of influence in the international arena: 
‘Russia in toto has implemented a relatively complex set 
of policies that appear set to present an explicit alternative 
agenda to proposals favouring greater harm reduction or 
decriminalisation at the next UNGASS summit in 2016.’ 
http://www.swansea.ac.uk/gdpo/ 
In October 2014 New Zealand’s regulatory framework 
for new psychoactive substances (NPS) was the subject 
of a ‘critical first assessment’ and discussion by a panel of 
international experts, published in the journal Addiction 
(109/10: pp.1580–94). Lead author Chris Wilkins describes 
the framework as ‘the world’s first pre-market approval 
regulatory regime for NPS’: introduced in July 2013, the 
new regime provides that where clinical trial data show that 
an NPS product poses a ‘low threat’, it may be approved 
for manufacture and sale. While applauding the attempt 
at regulation, Wilkins and the expert panel raised some 
serious concerns.
 ■ Evaluation criteria: Wilkins points out that standard 
medical clinical trials may not capture data relevant to 
recreational drugs, e.g. binge use, polydrug use, use by 
vulnerable groups and high-risk modes of administration. 
Lisia van Diemen points out that as a therapeutic effect 
is not the aim, the dosage of the product that is to be 
tested may be too low to detect any side-effects: the 
sample size of the product to be tested must be sufficient 
to detect side-effects. 
 
For Alison Ritter, the key problem is that medical models 
of drug evaluation focus on therapeutic efficacy, e.g. 
alleviating symptoms, improving health and/or treating 
a disorder, and ignore the pleasure obtained from 
recreational drug use. She suggests it is possible to 
measure ‘pleasure outcomes’, and that users may be 
prepared to bear some degree of risk in exchange for the 
stated outcome. 
 ■ Market dynamics: Wilkins identifies possible distortions 
in the legal market for NPS. The overt advertising of 
approved NPS products may make it difficult to suppress 
the illegal market in unapproved NPS products as 
they may appear identical to the approved versions. 
Lisia van Diemen asks what incentives exist for NPS 
manufacturers to submit their drugs for approval: it is 
an expensive and time-consuming exercise and many 
existing manufacturers are already operating successfully 
in the illegal market. Anne Line Bretteville-Jensen adds 
that manufacturers in the prevailing illegal environment 
have had little incentive to consider safety matters such 
as quality and consumer information, that maximising 
profits has been their main motivation, and why should 
they change now, particularly if, after the long evaluation 
process, their products are not approved, or are 
approved but do not succeed in the legal market place? 
 
Brendan Hughes and Paul Griffiths of the EMCDDA 
compare the New Zealand regulatory framework with 
that adopted in the EU, where responsibility for and cost 
of assessment does not lie with the producer, and the 
EU does not take any action with regard to substances 
deemed ‘low risk’ but does prohibit a consumer market 
for ‘moderate risk’ substances and controls ‘high risk’ 
substances. They discuss three EU member states – 
Poland, Romania and Ireland – that have introduced 
legislation banning the supply of any unregulated NPS 
that do not meet certain criteria until specific permission 
is given. They note that Poland and Romania also have 
‘pre-market approval regimes’.  
 
Van Diemen, as well as Hughes and Griffiths, question 
whether legalising an NPS with no therapeutic effect will 
either reduce the introduction of other unregulated NPS  
or reduce the illegal use of controlled drugs. They  
argue that, to date, there is no evidence to support  
these assumptions.
 ■ Attitudes to risk and prohibition: Wilkins points out 
that what constitutes ‘low risk’ is not defined in the 
New Zealand legislation. Having discussed the need 
to consider the pleasure benefits derived from NPS 
use, Ritter concludes that unless the debate on drug 
regulation addresses the benefits as well as the risks of 
drug use, if it continues to focus on the risks alone, ‘it is 
unlikely that regulatory schemes will be able to resolve 
the bias of decision-makers towards prohibition’. 
  Looking at the drugs, rather than the users, Stephen 
Rolles and Danny Kushlick of the Transform Drug Policy 
Foundation argue that it is prohibition that is driving 
the NPS phenomenon: as long as certain categories of 
psychoactive substances are prohibited, manufacturers 
will continue to try and replace prohibited substances 
with uncontrolled ones. They comment: ‘It is reasonable 
to speculate that no substantial market for synthetic 
cannabinoids would have emerged had cannabis been 
available via a legally regulated market-place, not least 
because evidence suggests that users prefer cannabis, 
and synthetic cannabinoids products appear to be more 
risky in terms of more adverse health effects.’
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On 9 September 2014 the Global Commission on Drug Policy released Taking 
control: pathways to drug policies that work. Anticipating the debates at UNGASS 
2016, the Commission proposes five pathways whereby governments may 
‘improve the global drug policy regime’:
1.  put people’s health and safety at the centre of  
the picture,
2. ensure access to essential medicines and pain control,
3. end the criminalisation and incarceration of users,
4.  provide targeted prevention, harm reduction and treatment strategies for 
dependent users, and 
5.  regulate drug markets and adapt enforcement strategies to target the most 
violent and disruptive criminal groups rather than low-level players.
The Global Commission calls on governments to ‘rethink the problem, do 
what can and should be done immediately, and not to shy away from the 
transformative potential of regulation.’ www.globaldrugcommission.org 
(Compiled by Brigid Pike)
Urban and rural youth attending a 
treatment centre 
Murphy and colleagues analysed data collected about a 
cohort of young people aged under 21 who presented for 
treatment for substance use to the Matt Talbot treatment 
service between 2001 and 2011.1 The aim of the study was 
to investigate the differences in substance use between 
young people residing in urban and rural areas. The cohort 
consisted of 436 young people; just over half (51.3%) were 
rural attendees – 223 from Cork County and one from Kerry 
(rural attendees) and 212 from Cork City (urban attendees). 
Young males accounted for over 95% of both urban and 
rural attendees; overall, both groups had a similar mean age, 
urban attendees with a mean age of 16.7 years and rural 
attendees 16.8 years. Over 90% of both groups resided with 
their parents. 
Employment and education status 
The groups differed markedly in terms of current 
employment and education status. A third (33.3%) of urban 
attendees reported being unemployed compared to 22.2% 
of the rural group; 10.3% of rural attendees were in paid 
employment compared to 4% of urban attendees. A higher 
percentage of rural attendees (47.4%) reported to be a 
student compared to 37.4% of urban attendees; however, 
urban attendees made up a higher percentage of those 
attending an adult training course (22.2%) compared to 
17% of rural attendees. 
Problem substance use 
Over half of both groups (59.6% rural attendees and 54% 
urban attendees) presented for treatment for cannabis use 
as their main problem substance. Marked differences were 
observed between both groups for problems with alcohol 
use and benzodiazepine use. A higher percentage of rural 
attendees (32.3%) presented for treatment for problem 
alcohol use, in contrast to 22.5% of urban attendees; 
conversely, 16% of urban attendees compared to 4% of rural 
attendees reported presenting for treatment for problem 
benzodiazepine use. With regard to ‘head shop’ drugs, 4.2% 
of urban attendees presented for treatment for problem use 
of these substances, compared to 0.9% of rural attendees. 
Less than 2% of the overall cohort reported opioids as their 
main problem substance, while a slightly higher percentage 
of rural attendees (2.2%) reported problems with cocaine 
compared to 1.9% of urban attendees. 
Poly-substance use 
A higher percentage of urban attendees reported poly-
substance use: 73.7% reported using at least three different 
substances during their lifetime compared to 52.2% of rural 
attendees; 49.3% of the urban group reported using three 
different substances in the last month compared to 31.3% 
of rural attendees; and daily use of at least two different 
substances was reported by 11.3% of urban attendees 
compared to 4.9% of rural attendees. 
Initial use of substances 
There were no marked differences in age of first use of any 
substance, with the mean age for urban attendees being 
12.4 years and rural attendees 12.7 years. The vast majority 
of both urban (81.7%) and rural (80.9%) attendees reported 
cannabis as the first substance used. A higher percentage 
of urban attendees (4.1%) reported benzodiazepines as 
first substance used compared to 1.5% of rural attendees, 
and 6.1% of urban attendees reported inhalants as first 
substance used compared to 0.5% of rural attendees. On the 
other hand, 16% of rural attendees reported alcohol as first 
substance used compared to 7.6% of urban attendees. 
Towards UNGASS 2016 (continued)
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Referral to treatment 
A higher percentage of rural attendees (44.3%) compared 
to urban attendees (37%) were referred for treatment by the 
Irish legal system; this finding suggests these attendees were 
likely to have experienced problems with crime and/or social 
misbehaviour. 
Concluding remarks
The authors point out that this is the first Irish study 
comparing service users from urban and rural settings; on 
this basis alone the study is welcome as it helps to close 
a gap in the literature. The main aim of the study was to 
investigate differences in substance use between young 
people residing in urban and rural areas. 
The main differences found were:
1.  almost a third of the rural group presented for treatment 
for alcohol use as their problem drug, in contrast to 
22.5% of the urban group, 
2.  16% of the urban group presented with benzodiazepine 
as their main problem drug, in contrast to 4% of the 
rural group, and 
3.  a higher proportion of the urban group reported using 
a variety of substances during their lifetime, during the 
past month and during the past week. 
(Martin Keane) 
1. Murphy KD, Byrne S, Sahm LJ, Lambert S and McCarthy S 
(2014) Use of addiction treatment services by Irish youth: 
does place of residence matter? Rural and Remote Health, 
(14): 2735 http://www.drugsandalcohol.ie/22461/
Psychiatric and psycho-social 
characteristics of suicide completers
A recently published article examines the psychiatric and 
psycho-social characteristics of people dying by suicide in the 
West of Ireland.1 As background, the authors note national 
statistics showing that between 2001 and 2013 there were 
approximately 500 deaths by suicide in Ireland, and that 
the incidence of suicide among Irish males was four times 
greater than among females. The authors also cite a WHO 
report showing that, while the rate of death by suicide in 
Ireland is the eighth lowest in Europe compared to 26 other 
countries, in the 15–24-year-old age group Ireland ranks 
fourth highest.
The authors list the large number of potential risk factors for 
death by suicide that have been recognised in the literature. 
Psychological autopsy studies have shown that 60% to 90% 
of individuals have suffered with a psychiatric illness before 
their death by suicide. Alcohol abuse and/or psycho-active 
substances as well as borderline personality disorder have 
been highlighted as risk factors. There is an increased risk if 
the person has experienced adverse childhood trauma such 
as a violent episode or sexual abuse, although confounding 
factors need to be considered. Previous contact with mental 
health services and prior suicide attempts have also been 
found to be significant risk factors: the first two weeks 
following discharge are the period when individuals are at 
most risk. Other epidemiological studies show that genetic 
factors, independent of mental illness, are another important 
risk factor to consider for suicide. 
Previous episodes of deliberate self-harm are also a major 
risk factor for death by suicide: studies assessing self-harm 
have shown that 52% to 63% of individuals who have had 
one or more episodes of self-harm have later died by suicide. 
Death by hanging has been shown to be the most common 
method of suicide. Gender differences have also been found, 
with hanging and death by firearm more prevalent among 
men and self-poisoning more prevalent among women.
Aim and objectives
The aim of the study was to identify the demographic, 
psycho-social and clinical characteristics of individuals known 
to mental health services who died from probable suicide in 
the West of Ireland (HSE West region including West Galway, 
East Galway and Roscommon). The study examined each 
individual’s method of death and toxicology findings at time 
of death. It also characterised previous deliberate self-harm 
and suicide attempts and mental health diagnoses. 
Method
All post-mortems carried out in University College Hospital 
Galway (UCHG) between January 2006 and May 2012 
(n=1,991) were reviewed. The post-mortem reports, which 
included detailed reports from the consultant pathologist, 
witness statements, garda summaries and toxicology reports, 
were assessed against the study inclusion criteria, and 181 
individuals were determined to have died by probable 
suicide. Of these, 57 individuals were found to have been 
known to the mental health services and these individuals 
formed the cohort for the study. 
Results
There were more males to females in the study cohort (ratio 
4:1), the majority were unemployed (58%) and the mean 
age was 47 years. The highest proportion was aged between 
34 and 55 years (Table 1).
Table 1: Age group of individuals who died probably by 
suicide in HSE West, January 2006–May 2012
Age n %
18–34 17 30
34–55 22 39
55+ 18 32
Urban and rural youth (continued)
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Many individuals had a history of identifiable risk factors:
 ■ A recurrent depressive disorder or a major depressive 
episode was the most common psychiatric diagnosis 
(44%), followed by alcohol dependence syndrome (35%). 
 ■ Eight individuals with depression (32%) were alcohol 
dependent or made harmful use of alcohol. 
 ■ 23% suffered from chronic pain, with six of these 
individuals reporting a chronic medical illness. 
 ■ 44% had a history of adverse childhood experiences.
 ■ Those with chronic pain (23%) had higher rates of 
childhood trauma compared to those without a history.
Attendance at mental health services was as follows:
 ■ 33 individuals (58%) were still registered (actively 
attending) mental health services at the time of  
their death;
 ■ 20 individuals (35%) had been in contact with the mental 
health service in the month before their death; and 
 ■ 40 individuals (70%) had been previously admitted to 
a psychiatric unit, of whom eight had been discharged 
within a month of their death.
Table 2 sets out the methods of death. It shows that hanging 
was the most commonly used method (58%), followed by 
drowning (23%). 
Table 2: Methods of death
Method of death n %
Hanging 33 58.0
Drowning 13 22.8
Overdose 7 12.3
Other* 4 6.9
*  Other methods included gunshot and road 
traffic accidents.
Suicide had been previously attempted by 37 individuals 
(65%), with 11 (19%) having made three or more attempts. 
All individuals who were reported to have had chronic pain 
(n=13) had had at least one previous suicide attempt. Table 
3 shows that overdose was the most common previously 
attempted method of suicide, followed by attempted hanging. 
Fourteen individuals had previously attempted hanging, with 
11 of these (79%) later dying by the same method. 
Toxicology reports were available for 56 individuals (see Tables 
4 and 5). Antidepressants and benzodiazepines were the 
most common medications identified. Of those individuals 
with a history of depression, only nine had antidepressants 
detectable in their toxicology. Only one of the five individuals 
who had been previously diagnosed with schizophrenia had 
antipsychotic agents in their toxicology. Thirty-four individuals 
had no alcohol in their blood at the time of death. Of those 
who did, 11% had levels above 200mg%.
Table 4: Toxicology data obtained from  
post-mortem reports
Toxicology (drugs) n %
No drugs detected 25 44.6
Antidepressants 19 33.9
Benzodiazepines 16 28.6
Analgesics 9 16.1
Antipsychotics 7 12.5
Opiates 4 7.1
Mood stabilisers 4 7.1
Hypnotics 4 7.1
Cocaine 2 3.6
Table 5: Alcohol level at post mortem (mMol/1)
Toxicology (alcohol level) n %
None detectable 34 60.7
1–79mg% 9 16.1
80–199mg% 7 12.5
>200mg% 6 10.7
Conclusions
The study found that a history of previous attempted 
hanging was an important predictor of ‘completed suicide’ 
by hanging. The authors concluded that local policy for 
admission should reflect this risk. 
The study also confirmed that recent discharge from 
inpatient service is a time of increased risk of completing 
suicide. Toxicology results also showed that less than 
one third of the individuals were taking their prescribed 
medication. The authors deemed this a high rate of non-
compliance with treatment, and an important risk factor to 
consider when working with this group of patients. 
High rates of adverse childhood experience were reported in 
the case notes of individuals who died by probable suicide. 
The high levels of suicide attempts and/or deliberate self-
harm show that a greater emphasis needs to be given to 
the national clinical programme for the management of 
self-harm.
While alcohol was not detected in 60% of individuals, it is 
still an indicator of increased risk. 
(Linda O’Connor)
1.  Kielty J, van Laar A, Davoren M, Conlon L, Hillick A, 
McDonald C and Hallahan B (2014) Psychiatric and psycho-
social characteristics of suicide completers: a comprehensive 
evaluation of psychiatric case records and post-mortem 
findings. Irish Journal of Psychological Medicine, available at 
CJO2014. doi:10.1017/ipm.2014.47
Suicide completers (continued)
Table 3: Previous suicide attempts
Method of 
death
Attempted 
hanging n (%)
Attempted 
drowning
n (%)
Attempted 
overdose n (%)
Attempted 
cutting n (%)
Attempted 
poisoning n (%)
No previous 
suicide attempts 
n (%)
Hanging 11 (13.3) 3 (9.0) 14 (42.4) 3 (9.0) 5 (15.2) 10 (30.3)
Drowning 1 (7.7) 2 (15.3) 6 (46.2) 1 (7.7) 0 (0.0) 7 (53.8)
Overdose 1 (14.3) 1 (14.3) 5 (71.4) 1 (14.3) 1 (14.3) 1 (14.3)
Other* 1 (25.0) 1 (25.0) 1 (25.0) 0(0.0) 0(0.0) 2 (50.0)
Total 14 7 26 6 6 20
* Three individuals died by gunshot and one by crashing a vehicle at high speed.
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HRB publishes drug and alcohol 
evidence reviews
In December 2014 the Health Research Board published the 
first two issues in its drug and alcohol evidence review series. 
The reviews are on the topics of prevention1 and recovery 
capital.2 The series is part of the process of knowledge 
transfer and exchange between the HRB and those engaged 
in developing and implementing responses to problem 
drug and alcohol use in Ireland. The reviews are intended to 
support drug and alcohol task forces, service providers and 
policy makers in using research-based knowledge in their 
decision-making, particularly in regard to assigned actions in 
the National Drugs Strategy. 
Topics for review are selected following consultation with 
stakeholders to identify information gaps and to establish 
how the review will contribute to evidence-based selection 
and implementation of effective responses. 
The authors of the first two reviews used a technique known 
as Rapid Evidence Assessment (REA) which is designed to 
get to grips with available research evidence on a policy 
or practice issue, as comprehensively as possible within a 
limited period. To determine if there was a solid evidence 
base in the two chosen areas, the researchers looked at (1) 
the quality of research studies that make up the body of 
evidence, identifying well designed and executed studies that 
used reliable measures to assess if something worked; (2) the 
quantity of studies, as the strength of the evidence depends 
on the number of studies that have tested a particular 
approach; (3) the consistency of the findings produced by 
those studies, to see how many report the same or similar 
findings; and (4) the social context in which the research 
was done.
Some of the findings from the two reviews are 
presented here.
Efficacy and effectiveness of drug and alcohol 
abuse prevention programmes delivered outside 
of school settings
The researchers focused on studies published since 2008. 
Following their initial search they filtered the literature by 
quality and relevance. The review is based on 33 articles, 12 
of which are original research studies and 21 are reviews.
The research evidence suggests that while community-based 
approaches to preventing drug and alcohol abuse by young 
people are promising, the evidence is not strong enough 
to say with certainty which specific programmes work best. 
Some good-quality evaluation studies have measured the 
impact of community-based drug and alcohol prevention 
programmes but there are not yet enough studies looking 
at the same kind of services in a way that would tell us what 
works best. Several studies are good, using appropriate 
research designs and reporting their results properly, 
but many failed to implement the research methods 
effectively, or did not adequately report data from their 
outcome measures.
Despite this we can say that the literature does support 
community-based prevention interventions that address the 
range of social and personal issues typically faced by young 
people who experience difficulties arising from substance 
abuse. There is potential in multi-dimensional or multi-
model approaches. There are many published evaluations 
of standardised prevention programmes supported by clear 
instructions and manuals, many of which involve working 
with the families of young people. They typically include 
work to address family functioning, parental support, 
monitoring children’s behaviour and normative beliefs, 
social skills, and self-efficacy. Evidence for impact of family 
interventions such as Communities That Care (CTC), 
Strengthening Families Program (SFP) and Focus on Families 
(FOF) is promising. 
Because they each look at different approaches to 
prevention, and tend to use different ways of measuring 
outcomes, it is impossible to pull results from good-quality 
studies together to get a clear picture of what works best. 
This inconsistency could be overcome if services would agree 
to use a common set of measures to assess impact. This 
would help to increase understanding of what works best 
and for which client groups, facilitate the sharing of good 
practice and, ultimately, build a solid body of evidence.
Developing shared outcome measurement would involve 
services working together to identify what is common in the 
reasoning behind choosing particular programmes and the 
similarities in their delivery. They could then also work to 
develop common data collection systems.
Role of social and human capital in recovery 
from drug and alcohol addiction
This review looked at recent evidence of how social capital 
can make a difference to people recovering from drug and 
alcohol addiction. The authors focused on studies published 
since 2008. Following their initial search they filtered the 
literature they found by quality and relevance. The review 
is based on 26 articles, 21 of which are original research 
studies, and 5 are reviews.
Research has consistently shown how important it is to 
understand the social lives of recovering addicts. A good 
social network seems to provide recovering addicts with a 
sense of their own self-worth, what psychologists call self-
efficacy. The extent to which friends and families support 
abstinence, the ability to be financially independent, a 
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safe and secure place to live and activities that provide 
alternatives to substance abuse all contribute to what 
researchers call ‘social capital’ or ‘recovery capital’. Having 
supportive friends or family helps to persuade recovering 
addicts that they can change their substance-abusing 
behaviour: friendships can provide a person in recovery with 
examples of success, knowledge that others care about what 
they are trying to achieve, and a sense that they are capable 
of planning their own lives. This kind of support is what 
may be provided through the social networking aspects of 
fellowships such as Alcoholics Anonymous (AA) and Narcotics 
Anonymous (NA).
One of the purposes of the research was to support  
task forces in identifying useful ways of measuring their  
work and the review found a number of examples of  
how the availability of social capital could be monitored. 
These include:
 ■ The Perceived Sense of Community Scale (PSCS) looks 
at the extent to which recovering addicts feel a sense of 
belonging to social groups they consider to be part of 
their community;
 ■ The Recovery Capital Scale (RCS) is a 35-item self-report 
questionnaire that can be administered as an interview;
 ■ The Assessment of Recovery Capital (ARC) scale is a brief 
and easy-to-administer measurement of recovery capital, 
designed for use as an outcome measure for dependent 
individuals in and out of treatment; and
 ■ Quality of Life (QoL) measures assess an individual’s 
satisfaction with life in general and provide a useful 
means of measuring personalised support.
There is good evidence that social capital contributes to 
recovery. The reviewers identified a number of areas in which 
further work needs to be done so that this process can be 
understood better. We need to know more about how self-
help groups provide a source of social capital; how the need 
for social support changes for people over the course of the 
recovery process; what types of social capital suit particular 
people and why needs in this area differ from person to 
person; and what are the financial costs and benefits of 
providing the kinds of support that will lead to recovery.
As in the prevention area, developing shared measurements 
for the impact services have on recovering drug users would 
both help to improve services and make achievements in 
this work more apparent. Service providers would need to 
identify shared ways of measuring social capital, consider 
how shared working with housing and other services could 
be improved and learn to collect information that will help 
contribute to cost-benefit analyses.
Hard-to-measure qualitative outcomes of community-based 
programmes, involving extensive collaboration between 
stakeholders, have been captured and these examples could 
be applied very usefully to evaluate programmes supporting 
recovery. It would be a significant achievement if different 
services were to use a common approach to measuring 
impact, as it would lead to better outcomes for the people 
using services and provide evidence that task forces play an 
integral and valuable part in responding to problem drug use 
in Ireland.
(Brian Galvin)
1.  Munton AG, Wedlock E and Gomersall A (2014) The role of 
social and human capital in recovery from drug and alcohol 
addiction. HRB Drug and Alcohol Evidence Review 1. Dublin: 
Health Research Board http://www.drugsandalcohol.ie/ 
23078/
 2. Munton AG, Wedlock E and Gomersall A (2014) The efficacy 
and effectiveness of drug and alcohol abuse prevention 
programmes delivered outside of school settings. HRB Drug and 
Alcohol Evidence Review 2. Dublin: Health Research Board 
http://www.drugsandalcohol.ie/23079/
HRB evidence reviews (continued)
Dr Barry Cullen, HRB board member, who launched the first two 
reports in the HRB’s Drug and Alcohol Evidence Review series,  
and John Bennet, Coordinator Finglas Cabra Drug and Alcohol  
Task Force.
Coordinators of local drug and alcohol task forces who attended the 
launch of the HRB’s drug and alcohol reviews in the HRB on the 3rd 
of December.
16
drugnet 
Ireland
EMCDDA’s new-look best-practice portal
The EU drugs agency (the European Monitoring Centre for 
Drugs and Drug Addiction) has a new-look best practice 
portal. Designed as a practical and reliable source of what 
works, and what doesn’t, in drug-related prevention, 
treatment, harm reduction and social reintegration, the 
portal helps practitioners and professionals to: 
 ■  identify tried and tested interventions quickly,
 ■  allocate resources to what’s effective,
 ■  evaluate and improve interventions applying practical 
tools, standards and guidelines, and
 ■  take better decisions, gaining  
from experience and expertise across Europe.
Summarising the evidence in plain language, demystifying 
terminology and answering real questions from the field 
(through a dynamic FAQ section), the re-designed portal 
provides an accessible tool to support the development 
of evidence-based interventions. Information is presented 
in top-level ‘answer sheets’, supplemented by underlying 
levels setting out the most recent evidence. Links to further 
information sources are available throughout the resource.
With the new portal, the EMCDDA aims to bridge the gap 
between scientific evidence and current practice in the drugs 
field. By enhancing the communication of evidence, it aims 
to promote the sharing of best practice between countries 
and better inform decision-making processes, both at 
national and European level. Intended as a ‘living product’, it 
will be regularly updated as new information and research on 
interventions emerge.
(Mary Dunne)
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National Drugs Rehabilitation 
Framework pilot evaluated
Arising from the recommendations outlined in the report 
of the Working Group on Drugs Rehabilitation,1 a National 
Drugs Rehabilitation Framework (NDRF) was developed.2 Its 
purpose is to improve the provision of rehabilitation services 
to current and former drug users by creating integrated care 
pathways (ICPs) with the co-operation of different service 
providers. The NDRF was piloted in a number of locations 
and the evaluation of the pilot was recently published.3 Ten 
sites were selected for the pilot, but the evaluators report 
that only six implemented the framework. 
As part of the evaluation, data were collected from 14 service 
users via a structured questionnaire and in-depth interviews. 
All 14 service users had completed an assessment as part of 
engaging with the NDRF, all had been allocated a key worker 
and two thirds had been allocated a case manager. When 
asked about their experience with their key workers and case 
managers, service users were generally very positive about 
the support they had received. They spoke about the benefits 
of connecting with services. For example, they highlighted 
care planning as a direct benefit; the majority had a clear 
idea of their goals and aspired to build on current successes. 
Overall, service users reported being satisfied with the service 
they had received through the NDRF. 
Data were also collected from 48 key workers/case managers 
and 19 service managers. Three quarters of key workers/case 
managers reported always engaging in care planning, and 
the remainder reported engaging sometimes; similar levels 
of engagement in inter-agency meetings were reported. 
Service managers reported some difficulty in undertaking 
comprehensive assessments with clients. All bar one service 
manager said care planning was being implemented but 
of these 18, all but three reported difficulties. Around three 
quarters of service managers reported some difficulty in 
implementing confidentiality protocols. Service managers 
also reported varying levels of access to support services 
such as addiction services, education and employment, 
housing, justice and law reform services. All service managers 
reported some engagement in inter-agency working but 
all reported some difficulty implementing service level 
agreements. Both service managers and key workers/case 
managers reported an improvement in communication, 
in sharing of information and in making referrals following 
implementation of the framework.
The authors point out that the evaluation was ‘an examination 
of procedures and process rather than outcomes, with input 
from mostly service providers’ (p. 80). This means that 
they do not know how the majority of service users were 
experiencing the work practices within the NDRF and do 
not know how effective these practices were in delivering 
identified outcomes. However, what they can say is that for a 
small number of service users engaging with the framework, 
their experience of care planning seems to have been 
beneficial. From the perspective of service providers, there 
were difficulties in implementing the NDRF; in particular, 
there was a need for better access to services for clients, 
including housing, education and employment. There was 
also an identified need for improved inter-agency working 
between services engaging with the framework. 
In conclusion, the authors suggest, ‘…there is much 
goodwill towards the framework and a real desire for it to be 
implemented and supported in full…’ (p. 97). They identify 
a number of overarching themes relevant to refining and 
implementing the framework in the future. A brief note on 
each theme is presented below. 
Sustainability
Fears were expressed that the momentum, which was said 
to have carried through from the publication of the NDRF 
to the pilot phase of implementation, could be lost when 
the pilot evaluation concluded. Respondents wanted a re-
emphasis of support for the principles of the NDRF from the 
relevant government departments. 
New ways of working
In many locations the introduction of case management was 
reported to be problematic. Linked to this were problems 
with inter-agency working. Moving from the principle of 
inter-agency working to its implementation has to be actively 
worked on; these issues can be resolved through strong and 
consistent leadership. 
Culture
New ways of working that are promoted in the NDRF, 
particularly inter-agency working, challenge existing 
cultures of working in the sector. Appropriate training to 
address these local cultural issues is required as part of 
implementation. 
Non-implementation
It came as a surprise to the authors that some sites were 
not implementing the framework. It would help if the 
requirements around implementation were more direct and 
less open to misinterpretation.
Client-centredness
Most respondents agreed with the principle of putting the 
client at the centre of care planning and case management. 
However, respondents in statutory services had differing 
views from those in non-governmental organisations, with 
the former displaying a greater degree of scepticism.
Framework instruments and information 
technology
There is a tension between rigorous documentation and 
excessive paperwork. The majority of service provider 
respondents felt that the framework errs on the side of 
the latter: it is not possible to track service users’ progress 
through the various steps in the framework, owing to 
the burden of paperwork and information technology 
requirements. 
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Structures
In the event of further of further evaluation, structures need 
to be strengthened in order to avoid a situation where pilot 
sites are unsure whether they are in or not, as happened with 
this evaluation.
Concluding remarks
This evaluation provides insights into how the NDRF is 
both perceived and used. Clearly there were differences in 
perceptions both within and across the sites that participated 
in the evaluation; on the one hand, there appears to be 
general support for the framework, while on the other hand, 
issues remain around some key components such as inter-
agency working. In addition, some service providers clearly 
have difficulties in implementing elements of the framework, 
for example care planning. 
(Martin Keane) 
1. Working group on drugs rehabilitation (2007) National 
Drugs Strategy 2001–2008: rehabilitation. Report of the 
working group on drugs rehabilitation. Dublin: Department 
of Community, Rural and Gaeltacht Affairs. http://www.
drugsandalcohol.ie/6267/
2. Doyle J and Ivanovic J (2010) National Drugs Rehabilitation 
Framework document. Dublin: Health Service Executive. 
http://www.drugsandalcohol.ie/13502/
3. Barry J and Ivers JH (2014) Evaluation report of the National 
Drugs Rehabilitation Framework pilot. Dublin: Health Service 
Executive. http://www.drugsandalcohol.ie/21600/ 
Quality Champions Training for 
addiction services
To help ensure drug treatment and rehabilitation outcomes 
are achieved and to maintain a high standard of client safety, 
Action 45 in the National Drugs Strategy 2009–2016 calls for 
the introduction of ‘a clinical and organisational governance 
framework for all treatment and rehabilitation services in 
Ireland’.
To implement Action 45, the Health Service Executive 
adopted the QuADS standards as the quality standards for 
drug and alcohol services in Ireland.1 It has also engaged the 
Quality Standards Support Project (QSSP) to ‘contextualise’ 
the QuADS for Irish addiction services.2
Among the supports developed by the QSSP for projects 
implementing QuADS is the Quality Champions Training. It is 
designed to enable the learner to develop the skills they will 
need to champion quality improvement in their service and 
is delivered as a series of multimedia-based learning modules 
through Moodle on drugs.ie. 
The modules are delivered in five sessions:
Session 1: Introduction to quality
Session 2: Organisation review and mapping
Session 3: Consultation 
Session 4: Policy writing
Session 5: Implementation and policy review
Taking into account the limited resources available in 
community and voluntary sector services, the online learning 
platform on drugs.ie/quality was developed to enable 
learners to access training free of charge, at a time that suits 
them and in a location convenient to them. When asked to 
rate the effectiveness of online learning on a scale of 1 to 
10 where 1 indicates very poor and 10 indicates excellent, 
participants so far have scored effectiveness at 8. Of the 
participants so far, 91% have self-reported an increase 
in their knowledge of quality standards after completing 
the training.
The training is accessed through a unique login, all learners 
need in order to participate in the course is access to a PC 
or laptop with internet access and basic computer skills. The 
learner can participate in the course at their own pace and 
complete it in under one day or over four weeks, and all 
for free.
Following a successful pilot roll-out of the course, Quality 
Champions Training is now open for registration. To find out 
more or to register for the course, contact Nicola Corrigan 
on nicola.corrigan@aldp.ie or quality@aldp.ie. 
1.  QuADS – Quality in Alcohol and Drug Services – is a quality 
standards framework developed in the UK by Alcohol 
Concern and SCODA in 1999. For more information on 
QuADS, see the Report of the HSE Working Group examining 
Quality & Standards for Addiction Services. 
2.  With the support of the HSE and Dublin’s North Inner-City 
Local Drugs and Alcohol Task Force, the QSSP works to 
support drug and alcohol services in Ireland. It supports 
projects to develop their services in line with good practice 
by providing a sustainable model to support the national 
development of good practice, providing learning supports, 
and facilitating the sharing of information between peer 
agencies in the development of good practice. For more 
information visit http://www.aldp.ie/services/quality_
standards_support_project or contact nicola.corrigan@aldp.ie 
NDRF pilot evaluated (continued)
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Coolmine Therapeutic Community 
annual report 2013
The Coolmine Therapeutic Community (CTC) annual 
report for 2013 was launched by journalist and TV and 
radio presenter Matt Cooper, on 17 October 2014.1 The 
report contains reports and statistics on CTC’s services, 
as well as information on its strategic partners, funders 
and supporters.
The year 2013 saw CTC celebrate its 40th year of 
providing treatment and rehabilitation services in Ireland. 
During the year Coolmine worked with over 1,000 people, 
supporting them and their families to overcome addiction. 
The annual report notes the continuing increased demand 
for CTC’s services, and the growth of homelessness and 
drug use. While there was evidence of an improving 
economic outlook, the benefit of this improvement had 
yet to reach those individuals most in need. In the course 
of 2013 Coolmine Lodge increased its occupancy rate to 
an average of 28 men, a 27% increase from an average of 
22 men in 2012. Ashleigh House catered for an average of 
18 women, a 50% increase from an average of 12 women 
in 2012.
Throughout 2013 CTC maintained its emphasis on 
evidence-based treatments which serve to enhance 
the therapeutic community model. The two residential 
centres – Coolmine Lodge and Ashleigh House – offer 
a range of interventions including therapeutic groups, 
health promotion, relapse prevention, social skills, self-
peer evaluation groups, art classes, computer courses, 
horticultural projects and complementary therapies. CTC 
staff completed training in mindfulness-based relapse 
prevention, mindfulness-integrated cognitive behavioural 
therapy and the ‘Parenting under Pressure’ programme, in 
addition to ongoing skill development and training in their 
core competencies. 
CTC stresses that it is through this ongoing commitment to knowledge transfer, skills development and maintenance of 
evidence-based treatments, together with an increase in front-line staff, that it saw an average increase of 9% in client 
retention in its rehabilitation programme during 2013. 
CTC strengthened its commitment to formal research by presenting the initial findings of a longitudinal outcomes study at 
the European Federation of Therapeutic Communities (EFTC) conference in September 2013. During this conference, CTC 
successfully bid to host both the European Working Group on Drugs Oriented Research symposium (EWODOR) in May 2014 
and the EFTC conference in 2017.
Table 1: Services offered by CTC, number of participants and outcomes, 20131 
Service
Total number  
of participants
Outcomes
Ashleigh House 63 women  ■ 13 clients completed a methadone  
detox placements 
 ■  40 mothers were worked with in Ashleigh House
 ■  19 mothers had their child (children) on site on a permanent basis
 ■ 21 (+ 2 not attending crèche) children were worked with and attended the 
full-time crèche
Coolmine Lodge 139 men  ■ 10 clients had a methadone detox and  
8 completed the detox
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Service
Total number  
of participants
Outcomes
Outreach 291 clients were 
worked with in our 
pre-entry groups.
 ■ 22 clients were seen by outreach services from Ashleigh House
 ■ 93 clients seeking methadone detoxification admission
 ■  388 clients attended Ana Liffey pre-entry groups
 ■  52 individual assessments completed locally by Coolmine Outreach Team
 ■  56 family three-way assessments completed
Drug-free Day 
Programmes
51 clients
Welcome 
Stabilisation 
Programme
29 clients
Family Support 
Services (either in 
group or 1-to-1)
56  
Career Guidance 
Service
828 individual 
sessions with 
Career Guidance 
Officer
 ■ 320 clients seen in group career guidance sessions
 ■ 88 clients applied for education/training
 ■ 24 internal and external placements on Community Employment (CE) 
Schemes 
 ■ 90 clients provided with literacy support
 ■ 10 clients took part in Business in the Community programme
 ■  63 clients gained placements or volunteer work
Contingency 
Management 
Programme
32 clients
(Vivion McGuire)
 1. Coolmine Therapeutic Community (2014) Annual report 2013. Dublin: CTC. http://www.drugsandalcohol.ie/22805/
Coolmine in 2013 (continued)
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Cuan Mhuire Lumen Initiative
On 15 September 2014 President Michael D. Higgins opened 
the Cuan Mhuire Lumen Initiative and the newly refurbished 
Teach Mhuire, located in Dublin’s Gardiner Street, which 
provides short-term accommodation for 55 homeless 
men who have completed a drug, alcohol, or gambling 
programme and who are in early recovery.
The Lumen Initiative offers residents of Teach Mhuire 
treatments such as group therapy, one-to-one counselling, 
assessment and referral, family support and relapse 
prevention groups. 
President Higgins spoke about the work of Cuan Mhuire, the 
importance of their work, and about homelessness. He noted 
that ‘lumen’ is the Latin word for light and that he hoped 
that the project would shine some light in to the lives of 
those who were most vulnerable. He spoke of the complexity 
surrounding homelessness, and how it is often linked to 
many other challenges and difficulties: 
They are people who know, from lived experience, that 
without a home, an address, citizens are also deprived in 
many ways of a voice in society; of the right to participate, 
to seek and obtain employment, to offer their skills and 
talents to their communities and their wider society. They 
are denied a sense of place, of home, of neighbourhood, 
and of shared solidarity and responsibility, which is critical 
to our living together.1
President Higgins also spoke about addiction and 
the damage that it has done to both individuals and 
families in Ireland. In conclusion, he unveiled a plaque to 
commemorate the occasion. 
Sr Consilio, who founded Cuan Mhuire in 1966, thanked 
President Higgins for attending and acknowledged his long-
standing friendship and support for the project. She spoke 
about the importance of valuing everyone equally and trying 
to ensure that those who are homeless are treated fairly. 
She acknowledged all the help and support that has been 
received over the years, without which Cuan Mhuire would 
not be able to exist.
The opening was attended by many supporters of Cuan 
Mhuire: the Lord Mayor, members of the Oireachtas 
and local councillors, current and past staff members, 
representatives of other agencies working in the area of 
homelessness and addiction, and donors, including staff of 
State Street Bank who had supported the refurbishment of 
Teach Mhuire.
(Suzi Lyons)
1. http://www.president.ie/speeches/speech-at-the-official-
opening-of-the-cuan-mhuire-lumen-initiative-gardiner- 
street-dublin/ 
MQI annual review 2013 
The Merchants Quay Ireland (MQI) annual review for 2013 
was launched on 11 September 2014 by the Lord Mayor of 
Dublin, Christy Burke.1 
MQI’s 17th annual review notes the continuing growth 
of homelessness and drug use. Whilst there is evidence 
of an improving economic outlook, the benefit of this 
improvement has not yet reached those individuals most  
in need. 
The New Communities Support Service provided one-to-one 
support to 250 service users mostly from Eastern European 
countries. The largest numbers of new community clients 
were from Poland.
MQI’s needle-exchange service recorded approximately 
22,898 client visits in 2013. The report highlights a 
continuing high level of demand for homelessness services: 
85,170 meals were provided by the day and evening 
services, and 4,467 health-care interventions were provided.
The year 2013 saw MQI continue to provide the national 
prison-based addiction counselling service to 13 prisons. 
Demand for this service continues to grow: 11,452 individual 
counselling sessions were provided, representing an 8% 
increase over 2012; 4,646 group attendances were recorded, 
representing a 27% increase. In Mountjoy Prison, MQI’s 
counselling service co-ordinates an inter-agency programme 
at the medical unit. 
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MQI in association with the Midland Regional Drugs Task Force and the HSE administers the Midlands Family Support and 
Community Harm Reduction Service, providing outreach and working with families of those actively using drugs in that task 
force region. In 2013:
 ■ The family support service provided 230 group sessions and 762 individual sessions, and 771 supportive phone calls. 
 ■ The harm reduction service provided on average 257 needle exchanges each month. 
 ■ Athlone Open Door Centre had 148 clients during 2013, recording 3,264 visits and providing 2,796 meals.
 ■ The Midlands Rehabilitation and Aftercare service worked with 41 individuals, providing 555 one-to one-sessions and 58 
group sessions.
Table 1: Services/interventions offered by MQI, number of participants and outcomes, 2013 
Service Type of intervention
Total number  
of participants
Outcomes
Needle-exchange and 
health-promotion 
services
•	 	Promotes	safer	injecting	
techniques 
•	 HIV	and	hepatitis	prevention
•	 Safe	sex	advice
•	 Information	on	overdose
•	 	Early	referral	to	drug	
treatment services
3260 used needle-
exchange services,  
of whom 614 were 
new clients
Stabilisation services Methadone substitution 20
Gateway programme 1251 service visits  
Integration programmes •	 Ballymount	House
•	 	Leixlip	House	with	Respond	
Housing Association
19 admissions to 
Aftercare Housing
Occupancy rate for Ballymount 
and Leixlip was 90%.
Training and work 
programmes
Community Employment scheme 81 Of the 28 who completed 
placements at MQI, 12 secured 
permanent employment;
1 moved to another course.
High Park 17-week, drug-free residential 
programme including individual 
counselling, group therapy, 
educational groups, work 
assignments and recreational 
activities
42 (of whom 9 
were admitted for 
detoxification)
100% of clients completed the 
full programme.
St Francis Farm Therapeutic facility offering a  
14- week programme.
46
Detox facility 70 
(Vivion McGuire)
1. Merchants Quay Ireland (2014) Annual review 2013. Dublin: MQI. http://www.drugsandalcohol.ie/22627/ 
MQI in 2013 (continued)
23
drugnet 
Ireland
Ruhama annual report 2013
On 5 November 2014 at the Alexander Hotel in Dublin, 
Senator Ivana Bacik launched Ruhama’s annual report for 
2013.1 The launch also marked the 25th anniversary of 
Ruhama’s work supporting women affected by prostitution 
and sex trafficking. Ruhama provides front-line services to 
these women and also advocates and lobbies for legislative 
and policy change to reduce the exploitation and harms 
associated with prostitution and sex trafficking. This article 
summarises the main reported activities from Ruhama’s 
front-line services during 2013. 
Street outreach
Ruhama provides practical support and information to 
women in street-based prostitution through its street 
outreach van. When Ruhama was set up in 1989, the first 
service it provided was this outreach support from a mobile 
van. The van now operates up to four nights a week: in 2013 
the service was provided on 130 nights and supported 70 
women, 10 of whom were referred on to Ruhama’s casework 
service. According to Ruhama, ‘…addiction to drugs and/
or alcohol is one of the main presenting issues for women 
in street prostitution…’ (p. 9). In addition, women present 
with issues around financial debt, homelessness, poor mental 
and physical health, suicide ideation and domestic violence. 
Ruhama provides information to women on its own services 
and those of other agencies which may be able to assist with 
the problems that women present with. 
Casework and care planning
The casework model that Ruhama uses involves a person-
centred care plan that responds to the holistic needs of the 
women. As such, each care plan is tailored to the unique 
circumstances of each woman. In 2013, 219 women were 
engaged in casework with Ruhama, 96 for the first time and 
123 continuing on from the previous year. The 219 women 
came from 36 different countries, and 83 of them were 
suspected of being victims of sex trafficking. According to 
Ruhama, ‘…the main focus of the care planning process 
is empowerment [of the women].…This 
process assists women in taking control of 
their lives…the process also endeavours to 
ensure that women make informed choices 
out of the options available to them…’  
(p. 10). By the end of 2013, 63 women  
had completed their care plans and moved 
on to new opportunities. 
Education and development
According to Ruhama, ‘Many of the women 
who access Ruhama’s services do not initially 
have the confidence for, or face barriers that 
restrict their uptake of, mainstream education 
and development opportunities…our 
Education and Development programme…
offers practical supports which equip women 
with the skills they need to proceed to further 
education or the employment market’  
(p. 12). In 2013, 68 women engaged with 
the education and development programme, 
which included group activities and one-to-
one sessions. 
Housing and social welfare
In 2013, 42 women were supported by Ruhama to secure 
housing, 32 were assisted to develop budgeting skills to 
manage their households, and 35 were supported with 
processing paperwork and completing forms relevant to the 
housing and budgeting processes. The women presenting 
to Ruhama reported difficulties in accessing suitable 
accommodation, in particular securing accommodation 
through the private rental market. Ruhama reports that ‘… 
2013 saw a marked increase in the number of Irish women 
accessing emergency or homeless accommodation in Dublin. 
For some the combination of homelessness and chaotic drug 
use further complicated women’s positions of vulnerability 
and drove them further into street prostitution’ (p. 15). 
Conclusion
Ruhama’s annual report for 2013 is a useful insight 
into the nature and extent of the work undertaken by 
the organisation. However, work of this kind with such 
vulnerable and marginalised women can rarely be captured 
by reference to numbers and categories. In the words of the 
chairperson of Ruhama: 
…This report contains many statistics, but behind each 
statistic is an individual woman’s story with her personal 
experience of prostitution. When women access our service 
they know they have no need to hide their experiences of 
prostitution; they will not be judged and will receive support 
to gain autonomy and make real choices (p. 3).
(Martin Keane) 
1. Ruhama (2014) Ruhama annual report 2013. Dublin: 
Ruhama. http://www.drugsandalcohol.ie/22900/
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From Drugnet Europe
New review on drugs and driving 
Cited from Drugnet Europe No 87, July–September 2014
An estimated 28,000 lives are lost on Europe’s roads every 
year and a further 1.34 million people are injured. Many 
of these accidents and deaths are caused by drivers whose 
performance is impaired by a psychoactive substance. 
Alcohol remains the number one substance endangering 
lives on European roads, but use of drugs and medicines 
behind the wheel, particularly when combined with alcohol, 
is a major challenge for policymakers. A new EMCDDA report 
— Drug use, impaired driving and traffic accidents — reviews 
the latest research in this field.1 
Released to mark International day against drug abuse and 
illicit trafficking (26 June), the report updates an EMCDDA 
literature review released in 2008. The new edition includes 
the results of the European Commission-funded DRUID project 
(2006–11), which contributed key evidence to road safety 
policy by mapping Europe’s drink- and drug-driving problem 
across 13 countries. Also examined are over 500 studies, 
published in Europe and internationally up to 2013, with a 
greater emphasis placed on meta-analyses and systematic 
reviews, which combine and summarise the latest findings. 
The report explores methodology, prevalence and the effects  
of substances on performance. It concludes: ‘The chronic  
use of all illicit drugs is associated with some cognitive  
and/or psychomotor impairment and can lead to a decrease 
in driving performance, even when the subject is no longer 
intoxicated’. Among concerns raised in the report is the variety 
of drugs available today: ‘The range of psychoactive substances 
available for illicit use is increasing, and recent studies are 
finding evidence of their use among drivers.’ 
1 Verstraete AG, Legrand SA and EMCDDA Project Group 
(Vandam L, Hughes B and Griffiths P) (2014) Drug use, impaired 
driving and traffic accidents 2nd edition. Lisbon: EMCDDA. 
Available at www.emcdda.europa.eu/publications/insights 
WHO–Europe launches new guide on prisons  
and health 
Cited from Drugnet Europe No 87, July–September 2014
On 27 May, the World Health Organization’s Regional 
Office for Europe (WHO–Europe) launched its latest guide 
for professionals working in the area of prison healthcare. 
The manual, entitled Prisons and health, was presented in 
Strasbourg at an expert meeting, co-organised by the Council 
of Europe’s Pompidou Group and the WHO’s Health in Prisons 
Programme, on the theme: ‘Prison health in Europe: missions, 
roles and responsibilities of international organisations’.2 
The manual is based on contributions from a large number of 
experts and international partners, including the EMCDDA. The 
guide outlines important proposals to improve the health of 
those in prison and to reduce the risks posed by imprisonment 
to health and society. In particular, it aims to facilitate better 
prison health practices in the fields of human rights and 
medical ethics; communicable diseases; non-communicable 
diseases; oral health; risk factors, vulnerable groups; and prison 
health management. 
Based on the principle of prison health being a key factor 
of public health, the meeting also adopted the ‘Strasbourg 
conclusions’. These highlight, among others: the right for 
prisoners to enjoy the same level of healthcare as others in 
society and the effectiveness of placing prison health services 
under the jurisdiction of health (rather than justice) ministries. 
In the text, international organisations pledge their support for 
prison health reform by strengthening and coordinating their 
efforts to ensure implementation of these conclusions. 
2 Enggist S, Moller L, Galea G and Udesen C (eds) (2014) 
Prisons and health Copenhagen: WHO Regional Office for 
Europe. Available at www.euro.who.int/en/publications/
abstracts/prisons-and-health 
New study on HCV infection 
Cited from Drugnet Europe No 87, July–September 2014
‘Hepatitis: Think again’ was the theme of this year’s World 
Hepatitis Day commemorated on 28 July. To mark the 
occasion, the open-access online journal PLoS ONE published 
a new EMCDDA systematic review of data for scaling up 
treatment and prevention among injecting drug users 
infected with hepatitis C in the EU.4 People who inject drugs 
(PWID) are a key population affected by the hepatitis C virus 
(HCV). Treatment options are improving and may enhance 
prevention; however, access for PWID may be poor. The 
new study, one of the largest conducted on this topic and 
involving over 80 collaborators, concludes that data on HCV 
epidemiology, care and disease burden among PWID in 
Europe, while sparse, suggest many undiagnosed infections 
and poor treatment uptake. The burden of disease, where 
assessed, was high and is expected to rise in the next decade. 
4 Wiessing L, Ferri M, Grady B, Kantzanou M, Sperle I, Cullen 
KJ, EMCDDA DRID group, Hatzakis A, Prins M, Vickerman 
P, Lazarus JV, Hope V and Matheï C (2014) Hepatitis C virus 
infection epidemiology among people who inject drugs in 
Europe – A systematic review of data for scaling up treatment 
and prevention PLoS One 28 July 9(7): e103345. Available at 
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.
pone.0103345.
The role of take-home naloxone in reducing 
overdose deaths 
Cited from Drugnet Europe No 87, July–September 2014
The role of take-home naloxone (THN) in reducing opioid-
related fatalities will be the focus of an EMCDDA meeting 
held in Lisbon on 14 October. Leading experts on the issue 
will come together at the event to focus on the scaling up of 
interventions using this medication across Europe. 
The WHO will present at the meeting its new Guidelines on the 
management of suspected opioid overdose while the EMCDDA 
will review its upcoming paper on the Effectiveness of take-home 
emergency naloxone to prevent heroin overdose. 
For more, see www.emcdda.europa.eu/topics/pods/
preventing-overdose-deaths 
Drugnet Europe is the quarterly newsletter of the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 
It is available at www.emcdda.europa.eu.
If you would like a hard copy of the current or future issues, 
please contact:
Health Research Board, Grattan House, 67–72 Lower Mount 
Street, Dublin 2. 
Tel: 01 2345 148; Email: drugnet@hrb.ie
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Recent publications
Journal Articles
The following abstracts are cited from recently published journal 
articles relating to the drugs situation in Ireland.
Gamma-hydroxybutyrate (GHB): a scoping review  
of pharmacology, toxicology, motives for use, and  
user groups
Brennan R and van Hout MC, Journal of Psychoactive Drugs, 
2014, 46(3): 243–251 
http://www.drugsandalcohol.ie/22862/
Gamma hydroxybutyrate (GHB) is a central nervous 
system depressant with euphoric and relaxant effects. 
Documentation of GHB prevalence and the under-reporting 
of abuse remains problematic, given the availability of GHB 
and its precursors γ-butyrolactone (GBL) and 1,4-butanediol 
(1,4-BD) and the ease of synthesis from kits available on the 
Internet. The continued abuse of and dependence on GHB, 
and associated fatalities, present an on-going public health 
problem. As the drug GHB remains an under-researched 
topic, a scoping review was chosen as a technique to 
map the available literature into a descriptive summarised 
account. PRISMA was used to assist in data retrieval, 
with subsequent data charting into three key themes 
(pharmacology and toxicology, outcomes, and user groups). 
Administered orally, GHB is dose-dependent and popular for 
certain uses (therapeutic, body enhancement, sexual assault) 
and amongst user sub-groups (recreational party-drug users, 
homosexual men). Despite the low prevalence of use in 
comparison to other club drugs, rising abuse of the drug 
is associated with dependence, withdrawal, acute toxicity, 
and fatal overdose. Clinical diagnosis and treatment is 
complicated by the co-ingestion of alcohol and other drugs. 
Limitations of the scoping review and potential for further 
research and harm reduction initiatives are discussed.
Life-time prevalence and psychosocial correlates of 
adolescent direct self-injurious behavior: a comparative 
study of findings in 11 European countries
Brunner R, Kaess M, Parzer P, Fischer G et al., Journal of Child 
Psychology and Psychiatry, and Allied Disciplines, 2014, 55(4): 
337–348
http://www.drugsandalcohol.ie/22792/
This study investigates the prevalence and associated 
psychosocial factors of occasional and repetitive direct 
self-injurious behaviour (D-SIB), such as self-cutting, 
-burning, -biting, -hitting, and skin damage by other 
methods, in representative adolescent samples from 11 
European countries.
Cross-sectional assessment of adolescents was performed 
within the European-Union-funded project, Saving and 
Empowering Young Lives in Europe (SEYLE), which was 
conducted in 11 European countries. The representative 
sample comprised 12,068 adolescents (F/M: 6,717/5,351; 
mean age: 14.9 ± 0.89) recruited from randomly selected 
schools. Frequency of D-SIB was assessed by a modified 
6-item questionnaire based on previously used versions 
of the Deliberate Self-Harm Inventory (DSHI). In addition, 
a broad range of demographic, social, and psychological 
factors were assessed.
These results suggest high lifetime prevalence of D-SIB in 
European adolescents. Prevalence as well as psychosocial 
correlates seem to be significantly influenced by both  
gender and country. These results support the need for a 
multi-dimensional approach to better understand the  
development of SIB and facilitate culturally adapted 
prevention/intervention.
A newly identified group of adolescents at ‘invisible’ risk 
for psychopathology and suicidal behavior: findings from 
the SEYLE study
Carli V, Hoven CW, Wasserman C, Flaminia C et al., World 
Psychiatry: Official Journal of the World Psychiatric Association 
(WPA), 2014, 13(1): 78–86
http://www.drugsandalcohol.ie/22790/
This study explored the prevalence of risk behaviours 
(excessive alcohol use, illegal drug use, heavy smoking, 
reduced sleep, overweight, underweight, sedentary 
behaviour, high use of Internet/TV/videogames for reasons 
not related to school or work, and truancy), and their 
association with psychopathology and self-destructive 
behaviours, in a sample of 12,395 adolescents recruited in 
randomly selected schools across 11 European countries. 
Latent class analysis identified three groups of adolescents: 
a low-risk group (57.8%) including pupils with low or very 
low frequency of risk behaviours; a high-risk group (13.2%) 
including pupils who scored high on all risk behaviours; and 
a third group (‘invisible’ risk, 29%), including pupils who 
were positive for high use of Internet/TV/videogames for 
reasons not related to school or work, sedentary behaviour 
and reduced sleep. Pupils in the ‘invisible’ risk group, 
compared with the high-risk group, had a similar prevalence 
of suicidal thoughts (42.2% vs 44%), anxiety (8% vs 9.2%), 
sub-threshold depression (33.2% vs 34%) and depression 
(13.4% vs 14.7%). 
The prevalence of suicide attempts was 5.9% in the 
‘invisible’ group, 10.1% in the high-risk group and 1.7% 
in the low-risk group. The prevalence of all risk behaviours 
increased with age and most of them were significantly 
more frequent among boys. Girls were significantly more 
likely to experience internalising (emotional) psychiatric 
symptoms. The ‘invisible’ group may represent an important 
new intervention target group for potentially reducing 
psychopathology and other untoward outcomes in 
adolescence, including suicidal behaviour.
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Risk-behaviour screening for identifying adolescents with 
mental health problems in Europe
Kaess M, Brunner R, Parzer P, Carli V et al., European Child 
and Adolescent Psychiatry, 2014, 23(7): 611–620
http://www.drugsandalcohol.ie/22789/
Indicated prevention of mental illness among youth is an 
important public health concern. The aim of this study was 
to establish a European school-based professional screening 
among adolescents, which included variables on a broad range 
of risk-behaviours and psychopathology, and to investigate the 
indicative value of adolescent risk behaviour and self-reported 
psychopathology on help-seeking and psychological problems 
that required subsequent mental healthcare. 
A two-stage professional screening approach was developed 
and performed within the multi-centre study ‘Saving and 
Empowering Young Lives in Europe’ (SEYLE). The first 
stage of screening comprised a self-report questionnaire 
on a representative sample of 3,070 adolescents from 11 
European countries. In the second stage, students deemed 
at-risk for mental health problems were evaluated using a 
semi-structured clinical interview performed by healthcare 
professionals. 61 % of participants (n = 1,865) were identified 
as being at-risk in stage one. In stage two, 384 participants 
(12.5 % of the original sample) were found to require 
subsequent mental healthcare during semi-structured, 
clinical assessment. Among those, 18.5 % of pupils were 
identified due to screening for psychopathology alone; 29.4 
% due to screening for risk-behaviours alone; and 52.1 % 
by a combination of both. Young age and peer victimisation 
increased help-seeking, while very low body mass index, 
depression, suicidal behaviour and substance abuse were the 
best predictors of referral to mental healthcare. 
Screening of risk behaviours significantly increased the 
number of detected students requiring subsequent mental 
healthcare. Screening of risk behaviours added significant 
value in identifying the significant amount of European 
pupils with mental health problems. Therefore, attention to 
adolescent risk behaviours in addition to psychopathology 
is critical in facilitating prevention and early intervention. 
Identifying factors that increase compliance to clinical 
interviews are crucial in improving screening procedures.
Modeling the impact of place on individual methadone 
treatment outcomes in a national longitudinal  
cohort study
Murphy E and Comiskey CM, Substance Use & Misuse,  
2015, 50(1): 99–105
http://www.drugsandalcohol.ie/22782/
From 2003 to 2006, 215 clients were recruited to a cohort 
study of methadone treatment. Participants had their address 
and clinic geocoded. Treatment outcomes were measured 
at intake, at one and three years post treatment using the 
Maudsley Addiction Profile instrument. Spider diagrams and 
buffer rings were used to visually map clinics and clients. 
Regression models were used to measure the effect of place. 
Results: Clients' accommodation and social and criminal 
problems in the region had a medium to large effect on 
heroin use. Analysis of buffer rings revealed that clients 
located within a 10-km radius of a major clinic demonstrated 
poorer outcomes in terms of heroin use. 
Conclusion/Importance: Findings illustrated the relevance of 
geography to drug treatment outcomes and the planning 
of services.
Regulatory approaches to new psychoactive substances 
(NPS) in the European Union
Hughes B and Griffiths P, Addiction, 2014,  
109 (10):1591–1593
http://www.drugsandalcohol.ie/22745/
As in New Zealand, three European countries (Ireland, 
Poland, Romania) have chosen to reverse the established 
control model, using effect-based definitions; the supply of 
any unregulated psychoactive substance that meets certain 
criteria is banned unless specifically permitted.
The association between family affluence and smoking 
among 15-year-old adolescents in 33 European countries, 
Israel and Canada: the role of national wealth
Pförtner T, Moor I, Rathmann K, Hublett A et al., Addiction, 
2014, Early online 
http://www.drugsandalcohol.ie/22734/
This study examines the role of national wealth in the 
association between family affluence and adolescent weekly 
smoking, early smoking behaviour and weekly smoking 
among former experimenters. Data were used from the 
Health Behaviour in School-aged Children (HBSC) study 
conducted in 2005/2006 in 35 countries from Europe and 
North America that comprises 60,490 students aged 15 
years. Multi-level logistic regression was conducted using 
Markov Chain Monte Carlo (MCMC) methods to explore 
whether associations between family affluence and smoking 
outcomes were dependent on national wealth.
Recent publications (continued)
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Upcoming events
March
March 2015
58th session of the Commission on Narcotic Drugs 
(CND): Special segment on preparations for the special 
session of the General Assembly (UNGASS) on the world 
drug problem to be held in 2016
Venue: Vienna
Further information: https://www.unodc.org/unodc/en/
commissions/CND/index.html?ref=menuside
Provisional agenda includes:
 ■ General debate on the special session of the General 
Assembly on the world drug problem to be held in 2016.
 ■  Interactive discussions on high-level workshops to be 
held during the special session of the General Assembly 
on the world drug problem: 
 (a)  Workshop 1: demand reduction and related issues — 
drugs and health;
 (b)  Workshop 2: supply reduction and related measures 
and countering money-laundering and promoting 
judicial cooperation — drugs and crime;
 (c)  Workshop 3: crosscutting issues — drugs and 
human rights, and youth, women, children and 
communities; 
 (d)  Workshop 4: drugs, sustainable development and 
international cooperation.
April
April 2015
Annual conference: Girls, women and alcohol
Organised by: Alcohol Action Ireland 
Further information: http://alcoholireland.ie/
Girls, women and alcohol will be the focus of Alcohol 
Action Ireland’s annual conference. During the conference, 
expert speakers will examine the factors influencing alcohol 
consumption and drinking patterns among Irish girls and 
women, the health risks involved, as well as what we need to 
do to bring about a positive change to the current situation. 
Women will also share their personal experiences of alcohol 
with conference attendees.
May
20–22 May 2015 
9th Annual Conference of the International Society for 
the Study of Drug Policy (ISSDP)
Venue: Ghent, Belgium
Hosted by: Institute for Social Drug Research (ISD), 
Department of Criminal Law and Criminology, Faculty of 
Law, University of Ghent
Further information: http://issdp.org/
Information: The ISSDP conference is held in May each 
year. The aims of the conference are to present original 
scientific research on drug policy; create opportunities for 
vigorous discussion and debate about findings and methods; 
provide an environment conducive for networking and the 
establishment of new collaborations; and provide a stimulus 
for delegates to publish their work in journals. Besides the 
plenary sessions, the 2015 ISSDP conference will offer space 
for panel discussions, poster sessions, and workshops. 
September
23–25 September 2015
First European conference on addictive behaviours  
and dependencies 
Venue: Lisbon
Organised by: Portuguese General Directorate for 
Intervention on Addictive Behaviours and Dependencies 
(Serviço de Intervenção nos Comportamentos Aditivos e nas 
Dependências — SICAD), the journal Addiction, the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 
and the International Society of Addiction Journal Editors 
(ISAJE). 
Web: http://www.lisbonaddictions.eu/html.cfm/
index231960EN.html
This conference will be a comprehensive and multi-
disciplinary event, showcasing leading European addiction 
research in the specialist areas of illicit drugs, alcohol, 
tobacco, gambling and other addictive behaviours. It 
will address new challenges and cover developing fields 
such as new psychoactive substances, online sales and 
gambling, cannabis legalisation and alcohol pricing. This 
conference will provide a unique networking opportunity 
for researchers, practitioners and policy experts across 
countries and disciplines to discuss latest findings on the 
prevention, treatment and control of addiction. It is the 
ideal venue to forge collaborative partnerships and explore 
funding opportunities.
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Just out
New ‘policy tool’ supports transparency and open debate
Identifying effective approaches to creating coherent policies 
regarding licit and illicit drugs has been the priority of the 
Pompidou Group during its 2010–14 work programme. It 
has produced four reports on the subject. The third report, 
published in 2012, proposed six markers around which the 
concept of coherency may be said to develop:1 
1. conceptualisation of the policy problem
2. policy context 
3. legislative and regulatory frameworks
4. strategic frameworks
5. responses/interventions 
6. structures and resources
In using these six markers the aim is to establish to what 
extent different drugs policies are in line with the concept of 
‘well-being’, which is part of the World Health Organization’s 
overarching goal in relation to licit and illicit drugs as well as 
other addictive behaviours such as gambling or the Internet. At 
the very least, the six aspects of policy highlighted by the six 
markers should not be in conflict with the overarching goal, and 
at best should contribute to its realisation. 
In 2013 and 2014 researchers refined the six markers and tested 
them in their countries, namely Croatia, the Czech Republic, 
Hungary, Ireland, Israel, Italy, Norway and Portugal, to verify 
whether they provided a valid tool to measure the coherency of 
policies on psychoactive substances with the overarching goal 
of the well-being. For each marker, the authors were asked to 
assess the level of coherency in their country, and this was then 
converted into a numerical value – thus, high=3, medium=2 
and low=1. The results were entered in a spreadsheet and 
converted into a spider diagram, with the high measure on 
the outer perimeter. This simple graphic representation shows 
at a glance the strengths and weaknesses of different policies 
and points the way to identifying options for strengthening 
policy coherency.
The results published in the most recent report, Coherency policy 
markers for psychoactive substances, indicate that such markers 
may indeed be used as a basis for discussion on the issue of 
coherence and in some cases as a means to better implement 
coherent policies in respect of psychoactive substances and also 
possibly other forms of addictive behaviour.2
Case study – Croatia 
The spider diagram contained in the report written by the 
Croatian Office for Combating Drug Abuse (see Figure 1) 
demonstrates how Croatia’s illicit drugs policy is by far the most 
coherent of all their policies relating to addictive behaviours, 
while gambling policy is the least coherent; alcohol and tobacco 
policies fall somewhere in between, although the strategic 
framework for implementing tobacco policy is substantially 
stronger than that developed for alcohol. 
Looking at the markers rather than the policies, it is evident that 
Croatia’s legislative/regulatory frameworks for each policy area 
are the most coherent in terms of contributing to the well-being of 
the Croatian population as a whole, while structures/resources 
and responses/interventions are the areas showing least 
coherency. This assessment can form the basis for an open  
and transparent debate on how to address the shortcomings.
Figure 1: Summary of the assessment of six markers for coherence of 
policies on illicit drugs, alcohol, tobacco and gambling, Croatia
The authors of the Croatian report describe how they facilitated 
discussion. After the relevant bodies and experts in charge 
of the co-ordination and implementation of policies on 
psychoactive substances and addictive behaviour had assigned 
values (high, medium or low) for each of the six makers, these 
same people were invited to form a focus group in order to 
give more detailed insights into the issues and to clarify any 
ambiguities. In addition, there was a detailed analysis of the 
key strategic documents. On the basis of this ‘triangulation’, 
the authors were able to identify a series of specific actions to 
strengthen the coherency of addiction policies.
(Brigid Pike)
1.  Muscat R, Pike B and Members of the Coherent Policy Expert  
Group Pompidou Group (2012) Reflections on the concept of 
coherency for a policy on psychoactive substances and beyond. 
Strasbourg: Council of Europe.
2.  Muscat R, Pike B and Members of the Coherent Policy Expert 
Group Pompidou Group (2014) Coherence policy markers for 
psychoactive substances. Strasbourg: Council of Europe. 
